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ABSTRACT 
Staphylococcus aureus coordinates gene expression at appropriate times throughout its 
life cycle. The work herein demonstrates S. aureus serine-threonine kinase (Stkl) can 
phosphorylate the response regulator GraR in vitro. Phosphorylation was confirmed by 
mass spectrometry and specifically occurs at the DNA-binding domain at three threonine 
positions: Thrl28, 130 and 149. Stkl could not phosphorylate BceR, a GraR homolog 
with 56% sequence similarity. We have also discovered, through in vivo work, novel 
phenotypes of an S. aureus ~graR knockout. It is shown that GraR plays a role in proper 
cell growth, division and wall teichoic acid maintenance. ~graR mutant complemented 
with ectopically expressed GraR-WT reverts phenotypes to normal, whereas GraR-D51N 
does not. Collectively our data suggest a novel, more global, regulatory role for the 
GraSR system. Understanding signaling and post-translational modification networks and 
their downstream effects is essential in order to rationally develop new strategies to treat 
S. aureus infections. 
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CHAPTER ONE 
INTRODUCTION 
1.1 Staphylococcus aureus 
1.1.1 A brief history 
In 1882 the Scottish surgeon Alexander Ogston examined pus under the 
microscope and based on morphology termed the bacteria Staphylococci, which is derived 
from the Greek words "staphyle," meaning bunch of grapes, and "kokkos," for berry 
(implying round) (Ogston, 1984). Two years later the German surgeon Anton Rosenbach 
isolated a strain of Staphylococci and based on colony appearance defined its species 
name: aureus, in Latin aurum means gold (Baird-Parker, 1990). Taken together the name 
Staphylococcus aureus literally means "bunch of golden, round grapes," which accurately 
describes both morphology and appearance. 
S. aureus is a Gram-positive facultative anaerobic bacterium that can survive in 
the presence or absence of oxygen. It is nonmotile, does not form spores and typically 
contains both catalase and coagulase enzymes. The catalase and coagulase tests are 
widely used to identify S. aureus and distinguish it from Enterococci and Streptococci. 
However, it should be stressed that S. aureus catalase- and coagulase- negative strains 
have been identified and caution should be exercised when using these tests to identify 
between organisms (Over et al., 2000; Thylefors et al., 1998). 
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1.1.2 Prevalence and pathogenesis 
S. aureus is ubiquitous and can be found everywhere in nature, from soil samples 
to livestock. It can also be found on inanimate medical objects such as prosthetics and 
catheters, which is why it is one of the most common causes of nosocomial infections 
(Deurenberg and Stobberingh, 2008). In the context of human health it is considered an 
opportunistic pathogen often associated with asymptomatic colonization of skin and 
mucosa! surfaces. Although no global statistics exist, a large-scale study in the United 
States from 2003 - 2004 found that 28.6 % of the population was colonized in the nose 
with S. aureus (Gorwitz et al., 2008). 
In many cases pathogenesis of S. aureus involves colonization and local 
infections, resulting in mild-skin infections such as boils and pimples. However, if the 
bacterium gets into the blood it can cause metastatic infections resulting in life-threating 
complications such as meningitis, pneumonia and septic shock (Archer, 1998). This 
pathogen can infect nearly every organ and tissue in the body, in part due to its extensive 
arsenal of immune evasion molecules and virulence factors (Kobayashi and DeLeo, 2009; 
Liu, 2009). Surprisingly, S. aureus maintains fine control over these genes and regulates 
them as required. Although a topic of debate, a recent study proposed that S. aureus might 
be able to survive intracellularly within neutrophils, which in turn act as Trojan Horses to 
spread the infection into distant parts of the body (Thwaites and Gant, 2011 ). This work 
sheds light on why some cases involving persistent bacteremia are difficult to treat, 
despite the presence of highly active, bactericidal antibiotics. 
2 
1.2 Antibiotics and drug-resistant Staphylococcus aureus 
1.2.1 Antibiotics 
Perhaps the greatest medical advance of the past-century, and arguably the 
greatest of all time, was the discovery that fungi produce toxins capable of killing bacteria 
that cause human diseases. In the 1890's French physician Ernest Duchesne demonstrated 
interaction between Penicillium glaucum, a mold, and the common intestinal bacterium 
Escherichia coli. He also showed that rats treated with a combination of P. glaucum and 
lethal doses of Salmonella typhi survived. Unfortunately, the researcher himself did not, 
and died of tuberculosis before fully completing his research. Sir Alexnader Fleming 
rediscovered this phenomenon by noting that bacteria in his petri dishes would not grow 
properly in the vicinity of the Penicillium mold. He published his findings in 1929 and 
handed the world its first antibiotic: penicillin (Fleming, 1980). 
The proceeding twenty years, referred to as "the Golden Age of antibiotic 
discovery," would supply modem medicine with roughly half of all the antibacterial 
drugs used today (Davies, 2006) and combined with increased public health measures 
mortality rates from infectious diseases dropped significantly. Before the introduction of 
antibiotics in the 1940's, the mortality rate for staphylococcal bacteremia was estimated 
to be 70 % (Spink, 1954 ). This rate dropped to 25 % as a result of penicillin. 
Unfortunately from the moment an antibiotic is introduced into the clinic, its usefulness 
lifetime begins to shorten as resistant strains arise and by 1954 mortality rates rose back 
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up to 45 %. In the late 1950' s, methicillin, a synthetic penicillin, was introduced to treat 
infections caused by penicillin-resistant S. aureus and within only two years methicillin-
resistant S. aureus (MRSA) strains were observed (Barber, 1961). This pattern of 
antibiotic introduction and resistance is demonstrated in Fig. 1.2.1. 
100 
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Figure 1.2.1 Mortality rates of staphylococcal bacteremia over time, adapted from 
(Dancer, 2008). 
Despite their effectiveness, as soon as an antibiotic is introduced into the clinic its 
usefulness declines with time and mortality rates rise. 
Antibiotics are chemical warfare agents that have been shaped through billions of 
years of evolution in bacteria and fungi. Therefore drug resistance is inevitable because 
after a billion years of making errors, most of the drug-resistant genes are out there 
somewhere. As a matter of fact, several years before the widespread use of penicillin as a 
therapeutic a group of scientists discovered a bacterial penicillinase in E. coli (Abraham 
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and Chain, 1988). 
Drug resistance is not necessarily a man-made artifact. Yes, misuse and abuse of 
antibiotics in the clinical setting has been a catalyst in facilitating the problem, but from 
the start we had a grossly unfair handicap in the arms race. Bacteria can evolve as much 
in a day as we can in a thousand years, which means mutations within the genetic 
material that bestow resistance arise spontaneously. Hence the problem with drug 
resistance is both the emergence of new genes in old germs and the convening of old 
genes with new hosts. 
To make matters worse the methods of discovering antibiotics are outdated and all 
the low-hanging fruit has already been picked, which explains why the rate of antibiotic 
discovery is declining (Nathan, 2004). As observed in Fig. 1.2.2 there exists an 
innovation gap, between the launch of quinolones in 1962 and the approval of 
lipopeptides in 2003, in which no new antibiotic classes made it to the clinic (Schriever et 
al., 2005; Walsh, 2003). There are several novel classes of antibiotics currently in human 
clinical trials and many more could be developed through better unde,rstanding of 
bacterial systems (Moir et al., 2012; Schneider and Sahl, 2010). 
1.2.2 MRSA, VISA and VRSA overview 
The struggle to keep MRSA infections at bay persisted beyond the 1960's. Within 
two decades MRSA was prevalent in hospital settings around the world (Schaefler et al., 
1981) and to make matters worse this organism started to present itself in the community, 
termed community-associated MRSA (CA-MRSA) (Saravolatz et al., 1982a; Saravolatz 
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et al., 1982b ). This was alarming because not only was this pathogen resistant to 
methicillin, but it was capable of infecting young healthy people in the community such 
as prisoners, athletes and those living in crowded areas with no connection to the health 
care setting. For example, between 1990 and 1995 the prevalence of CA-MRSA in a 
Chicago hospital increased from 10 to over 250 per 100,000 admissions (Herold et al., 
1998). 
Polyketides 
(ex. tetracycline) 
~-Lactams 
(ex. penicillin) 
Aminoglycosides 
(ex. gentamicin) 
Macrolides 
(ex. erythromycin) 
Glycopeptides 
(ex. vancomycin) 
? 
. 
Oxazolidinones 
(ex. linezolid) 
lipopeptides 
(ex. daptomycin) 
Pheny lpropanoids 
(ex. chloramphenicol) 
Quinolones 
(ex. ciprofloxacin) 
Streptogramins 
(ex. quinupristin/dalfopristin 
combination) 
Figure 1.2.2 Introduction of new classes of antibiotic into clinical practice, adopted 
from (Walsh, 2003) with updated information 
Note the "golden age of antibiotic discovery" between 1940 and 1960 and the innovation 
gap between 1960 and 2003. 
Genetic analysis revealed that CA-MRSA strains, such as USA300 and USA400, 
contain the staphylococcal chromosomal cassette (SCC) mec IV that renders them 
resistant to beta-lactams, such as penicillin and methicillin. However, the SCC mec 
cassette found in CA-MRSA is smaller than those found in hospital-associated MRSA 
(HA-MRSA) and thus provides less resistance than the larger SCCs (Hiramatsu et al., 
2001). But CA-MRSA tends to be more virulent than HA-MRSA and has been shown to 
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cause rapidly progressive, highly invasive life-threatening diseases (Adem et al., 2005; 
Mongkolrattanothai et al., 2003). 
Almost all CA-MRS A strains carry the Panton-Valentine-Leukocidin (PVL) gene, 
a virulence factor that is a key differentiator between HA- and CA- MRSA strains. This 
gene codes for an exotoxin that causes leukocyte destruction and tissue necrosis and has 
been suggested to be the main player in bestowing virulence characteristics to CA-MRSA 
(Boyle-Vavra and Daum, 2007; Etienne, 2005). 
The rise of MRSA in the 80's and 90's led to a dramatic revival of vancomycin, 
with a > 100-fold increase occurring over the next two decades (Kirst et al., 1998). It 
didn't take long for S. aureus strains to surface with reduced susceptibility towards 
vancomycin and other glycopeptides. In 1996 the first MRSA strain, termed MU50, was 
identified in Japan (Hiramatsu et al., 1997). This strain had a vancomycin minimum 
inhibitory concentration (MIC) of 8 µg/mL, and thus designated as vancomycin-
intermediate S. aureus (VISA). According to the National Committee for Clinical 
Laboratory Standards if an S. aureus strain has a vancomycin MIC :S 2µg/mL it is 
susceptible (VSSA), 4 - 8 µg/mL it is intermediate (VISA) and~ 16 µg/mL it is resistant 
(VRSA) (NCCLS, 2012). Although VISA and VRSA infections have been identified all 
over the world, their prevalence remains quite low (Howden et al., 2010). Nonetheless 
there is lingering concern that our early victories have accelerated the pace of drug 
resistance and the war on germs is an uphill battle in which our foes are showing strong 
signs of pulling ahead. Vancomycin, once considered the antibiotic of last resort, needs a 
7 
new substitute. 
1.3 First line of defense: the cell wall 
Figure 1.3.1 Diagram of the S. aureus cell wall 
Cell 
wall 
Cell 
membrane 
The S. aureus cell wall is composed of a thick, multilayered peptidoglycan (PG) on the 
exterior of the cytoplasm. The shorter fragments are wall teichoic acids (WT A) and are 
covalently embedded in peptidoglycan. The longer fragments are lipoteichoic acids 
(LT A) and are anchored to the cytoplasmic membrane. 
The cell membrane of S. aureus alone is not sufficient to provide the rigidity that a 
free-living organism requires. A thick single layer of peptidoglycan maintains the shape 
and integrity of the cell, as well as provides a protective interface for interaction with the 
external environment (Fig. 1.3 .1 ). It should be stressed that glycopolymers and proteins, 
both of which have highly variable and strain-specific roles, govern the composition of 
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bacterial cell walls (Clarke and Foster, 2006; Weidenmaier and Peschel, 2008). The 
bacterial cell wall is an ideal target for antimicrobial targets because no comparable 
structure exists in humans. Drugs that target these structures are typically very effective 
and have low toxicity. 
1.3.1 Peptidoglycan and its role in MRSA, VISA and VRSA 
Peptidoglycan (PG), also called murein, is composed of two alternating sugar 
derivatives, N-acetylglucosamine (GlcNAc) and N-acetlymuramic acid (MurNAc ), linked 
via a P-(1-4 )-glycosidic bond (Fig.1.3 .2). This is the bond that lysozyme, an antimicrobial 
enzyme that is part of the human innate immune system, can specifically recognize and 
enzymatically cleave. Unfortunately S. aureus is extremely resistant to lysozyme because 
the C-6 position of every second MurNAc residue is 0-acetylated (Bera et al., 2005). It 
has also been observed that high degree of PG cross-linking and wall teichoic acid 
(WTA) contributes to lysozyme resistance (Bera et al., 2007). 
In S. aureus the MurNAc residue is attached to a peptide stem made up of L -Ala-
o-Glu-L -Lys-o-Ala-o-Ala. The terminal o-Ala residue gets cleaved in the maturation 
process and the penultimate o-Ala gets attached to an L-Lys residue of a different 
MurNAc-GlcNAc unit via a pentaglycine bridge (Vollmer et al., 2008). Interestingly, this 
transpeptidation reaction is inhibited by P-lactam antibiotics, such as penicillin, whereby 
the antibiotic acts as a suicide substrate to irreversibly bind the transpeptidase active site 
of penicillin binding proteins. This mode of action prevents cells from forming 
pentaglycine bridges, which leads to loss of cell wall integrity and ultimately death. S. 
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Figure 1.3.2 Chemical structure of S. aureus peptidoglycan 
General peptidoglycan (PG) monomer composed of two sugars: N-acetylglucosamine and 
N-acetlymuramic acid. Polymers are linked via the pentaglycine interbridge from L-Lys to 
0 -Ala. Note terminal o-Ala gets cleaved in the mature PG. 
aureus employs two P-lactam resistance mechanisms: expression of blaZ, a P-lactamase 
enzyme that hydrolyzes P-lactam antibiotic and PBP2a, a penicillin binding protein that 
has very low affinity towards P-lactams and thus its transpeptidase domain remains 
active. The latter is encoded by the mecA gene, which is part of the SCC mec cassette and 
provides resistance against all P-lactam antibiotics in MRSA strains (Katayama et al., 
2000). 
Another important antibiotic that acts on the cell wall biosynthesis pathway is 
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vancomycin. Unlike ~-lactams, which bind penicillin-binding proteins and inactivate their 
active sites, vancomycin binds the terminal o-Ala-o-Ala of nascent PG precursors 
(Perkins, 1969; Watanakunakom, 1984). This binding prevents access of penicillin-
binding proteins to their natural substrates, and thus carboxypeptidase activity, which 
precedes transpeptidation, is inhibited. Although vancomycin and ~-lactams have 
completely different substrates and modes of action the end result is the same, cells are 
unable to carry out cell wall synthesis. 
Unlike ~-lactam resistance, intermediate vancomycin resistance is not due to the 
acquisition of new genes but more so the gradual alteration of PG biosynthesis. Several 
proteins, such as the global regulator Agr (Sakoulas et al., 2005) and the two-component 
system VraSR (Kuroda et al., 2004), have been suggested to play an important role in 
resistance. Based on clinical isolates, it was observed that all VISA strains have 
abnormally thickened cell walls. This phenotype is suggested to be the result of increased 
cell wall biosynthesis (Cui et al., 2003; Hiramatsu, 2001) and/or lower degree of PG 
crosslinking (Sieradzki and Tomasz, 1997). Increased cell wall biosynthesis, likely due to 
Agr and V raSR and their corresponding genes, increases cell wall thickness and thus 
prevents vancomycin from reaching its target. Decreased PG crosslinking, on the other 
hand, leads to an increase in mature PG and thus increased 0 -Ala-0 -Ala residues. 
Although vancomycin can bind mature o-Ala-0 -Ala, these act as decoys to trap 
vancomycin and prevent it from acting on its true target. Both of these defense strategies 
make it difficult for vancomycin to reach terminal 0 -Ala-0 -Ala of nascent PG. 
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VRSA strains, in addition to the above mentioned resistance mechanisms, employ 
yet another layer of defense against vancomycin. It should be noted that this is not a novel 
mechanism; high levels of vancomycin resistance were reported in 1988, in clinical 
isolates of Enterococcus species (Leclercq et al., 1988; Uttley et al., 1988). Furthermore 
in 1992 a British researcher demonstrated in vitro that vancomycin resistance can travel 
from Enterococcus to Staphylococcus (Noble et al., 1992). The scientific community 
hoped incompatibility would prevent the dreaded mating from ever occurring outside the 
test tube. Unfortunately in hospitals these two organisms often share close living quarters 
and it took only a decade for nature to reproduce the above-mentioned laboratory 
experiment. In 2002 the first VRSA strain was isolated with a vancomycin MIC of 1,024 
µg/mL (Centers for Disease and Prevention, 2002), in comparison a VSSA has a 
vancomycin MIC of 1 µg/mL. 
Genetic analysis rev~aled that VRSA strains contain an alternative pathway for 
nascent PG biosynthesis (Clark et al., 2005). The genes encoded in Tnl 546, a transposon 
carried on a plasmid, replace the carboxy o-Ala-o-Ala of nascent PG with o-Ala-o-Lac. 
Proper binding is facilitated by hydrogen bonds between vancomycin and 0 -Ala-0 -Ala; 
however, altering the structure to o-Ala-o-Lac prevents the substrate from fitting in the 
binding pocket of vancomycin. The analogy most often mentioned is that of a lock and 
key, where the lock, or the substrate, is altered so the key, vancomycin, no longer fits. 
Affo;iity of vancomycin to o-Ala-o-Lac is decreased by a factor of 1000 (Bugg et al., 
1991 ). There are other mechanisms by which the cell wall, specifically PG, contributes to 
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antibiotic resistance. But due to the clinical relevance of MRSA, specifically CA-MRSA, 
and VISANRSA much attention has been focused on ~-lactams and glycopeptides. 
1.3.2 Teichoic acids 
The S. aureus cell wall consists of two structural components: peptidoglycan, 
described above, and cell wall glycopolymers. These glycopolymers will be referred to as 
wall teichoic acids (WTA) (Fig. l.3.3A), those covalently attached to PG, and lipoteichoic 
acids (LTA) (Fig l.3.3B), which are anchored to the cytoplasmic membrane. WTAs are 
attached to MurNAc of the PG backbone via a linkage unit consisting of GlcNAc, 
MurNAc and two or three glycerolphosphate residues. The WTA repeating unit is 
composed of ribitolphosphate (RboP) that differs profoundly in length between 
subspecies and even individual strains, and has been shown to reach lengths of up to 40 
repeating units (Endl et al., 1983). LT As are attached to the cytoplasmic membrane by a 
diacylglycerol, which itself is attached to a disaccharide. The LT A repeating unit is 
composed of glycerolphosphate and is on average -23 units in length (Fischer, 1994). 
Previous studies have shown that WTA (Weidenmaier et al., 2004) is dispensable 
for viability whereas LTA is not (Grundling and Schneewind, 2007). An important 
modification of teichoic acids, which occurs in almost all strains, is the incorporation of 
0 -Ala. It should be noted that WTA Poly-RboP, in addition to 0 -alanylation, can also be 
glycosylated with either a- or ~- GlcNAc. Work by Brown et al. has demonstrated that 
glycosylation may be a contributor to methicillin resistance (Brown et al., 2012). 
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A) Wall teichoic acid (WTA) linkage unit is composed ofN-acetylglucosamine (GlcNAc) 
and N-acetlymuramic acid (MurNAc) followed by two to three 0 -alanylated glycerol 
phosphate residues. The WT A backbone on average ranges from 15 - 40 units of ribitol 
phosphates (substituted with 0 -Ala and/or a- or ~- GlcNAc ). B) Lipoteichoic acid (LT A) 
linkage unit is composed of a diacylglycerol connected to disaccharide. The LT A 
backbone on average is -23 units of glycerolphosphates (substituted mainly with 0 -Ala). 
Glycosylation of WT A is an emerging field and it remains to be seen what the 
physiological relevance is. Thus the remainder of this discussion will focus on 0 -
alanylation of teichoic acids, which has been extensively studied and reviewed 
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(Weidenmaier and Peschel, 2008). 
Teichoic acid net charge is profoundly altered when 0 -Ala groups are attached, 
resulting in a more positive charge (Neuhaus and Baddiley, 2003). This is especially 
important because the majority of antimicrobial molecules the cell encounters are 
positively charged and thus o-Ala decoration can repel these molecules. Accordingly, lack 
of o-alanylation has been shown to sensitize S. aureus towards antimicrobial peptides 
(Peschel et al., 1999). Furthermore, this modification has been implicated in adherence to 
host cells (Weidenmaier et al., 2005), biofilm formation (Gross et al., 2001), regulation of 
autolysis (Peschel et al., 2000) and cell growth (Tabuchi et al., 2010). 
The dltABCD genes, constituting the dlt operon, are responsible for 0 -Ala 
incorporation into WT A and LT A. This operon is exclusively under the regulation of the 
two-component system GraSR, also known as ApsSR (Li et al., 2007). It is beyond the 
scope of this work to go into detail regarding the specific genes and subsequent 
biosynthesis pathways of teichoic acids and their corresponding modifications. It is, 
however, important to understand that S. aureus commits vast amounts of genetic 
information, resources and energy to synthesize and maintain teichoic acids and their 
corresponding modifications. Given the importance of teichoic acids they remain a 
lucrative target for future drug development. 
1.4 Two-component systems 
S. aureus is able to adapt quickly to changes in its immediate environment, such 
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as variations in nutrient availability, osmolality, pH, temperature and antibiotic presence. 
Signal transduction mechanisms are responsible for sensing and responding to the above 
changes in the form of differential gene expression. In S. aureus, and many other 
prokaryotic organisms, this is accomplished by two-component systems (TCS), also 
known as sensor. kinase/response regulator systems. A typical TCS is made up of a 
histidine kinase, a cytoplasmic membrane protein capable of autophosphorylation (at a 
histidine residue) following an external stimulus and a response regulator protein that is 
capable of receiving this "message" in the form of phosphorylation (at an aspartic acid 
residue) and conveying it in the form of gene regulation (Stock et al., 2000). For a more 
up-to-date review of the field refer to the following papers (Capra and Laub, 2012; 
Casino et al., 2010; Laub and Goulian, 2007). 
According to the latest Microbial Signal Transduction database, MiST 2.1, in 
1,420 completed genomes analyzed to date, approximately 87,173 genes encode for TCS 
(Ulrich and Zhulin, 2010). The number and function of TCSs differs enormously from 
species to species, and this is likely the result of adaptation to the many environmental 
niches bacteria inhabit. According to MiST 2.1 there are 16 classical TCSs systems in the 
S. aureus 8325 genome and 17 in the MRSA strain MU50. Some of these TCSs have 
been extensively studied and well characterized, such as VraSR (Belcheva and Golemi-
Kotra, 2008), WalKR (Dubrac et al., 2008) and GraSR (Falord et al., 2012). Others are 
hypothetical and remain to be investigated. Given the proceeding chapters focus on the 
response regulator GraR, a brief introduction to the GraSR TCS will be presented. 
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1.4.1 The GraSR two-component system 
The GraSR, glycopeptide resistance associated, system is made up of GraS, the 
histidine kinase, and the response regulator GraR. In the literature this system was 
originally termed ApsSR, for antimicrobial peptide sensor (Li et al., 2007) based on 
homology with Staphylococcus epidermidis, but later renamed to GraSR. The GraS 
protein is presumed to function as a sensor kinase that possess a short-terminal sensing 
domain, and two transmembrane helices separated by a short loop that is buried in the 
cytoplasmic membrane. GraR, on the other hand, belongs to the OmpR subfamily of 
response regulators, which are categorized by a unique C-terminal winged helix-turn-
helix domain (Martinez-Hackert and Stock, 1997). 
It is presumed that GraS, following autophosphorylation, 1s capable of 
phosphory lating the aspartic acid residue at position 51 of the cognate response regulator 
GraR. Phosphorylation of GraR likely alters its binding affinity to DNA through 
conformational changes within the protein (Johnson and Barford, 1993). Neither 
phosphorylation of GraR nor DNA-binding has been reported in vitro. However, through 
microarray analysis and in vivo examination of knockout strains it was determined that 
GraSR regulates mprF, vraFG and the dlt operon (Cui et al., 2005; Falord et al., 2011). 
In section 1.3 .2 it was demonstrated that regulation of the dlt operon, by GraSR, is 
responsible for o-alanylation of T As that maintains an overall positive surface charge to 
repel antimicrobials. The mprF gene is a lysyl-phosphatidylglycerol synthase that also 
contributes to an overall positive surface charge by adding lysine to phosphatidylglycerol 
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within the cell membrane (Oku et al., 2004). The VraFG genes code for an ABC 
transporter, which is suggested to sense antimicrobial peptides, however characterization 
of this system is in its infancy (Falord et al., 2012). Numerous studies have observed that 
point mutations within the GraSR system can lead to VISA and VRSA phenotypes (Cui et 
al., 2009; Neoh et al., 2008; Yoo et al., 2013), which is likely explained through increased 
expression of mpr F and dlt operon. 
Despite the importance of GraSR in conferring resistance to antimicrobial 
peptides, a recent study has suggests a more global role for this system that is not limited 
to the expression mprF, .vraFG and the dlt operon (Falord et al., 2011). Microarray 
analysis revealed that 424 genes are differentially expressed in the S. aureus 11graSR 
mutant strain. Furthermore in silico genome scanning uncovered 26 novel potential GraR-
binding sites. Taken together this study demonstrates for the first time novel links to the 
virulence, stress response and cell wall signal transduction pathways (Falord et al., 2011 ). 
1.5 Signal transduction by Ser/Thr protein kinases 
It was previously assumed that Ser/Thr kinases (STKs) were exclusive to 
eukaryotic systems and the predominant signaling pathways in prokaryotes were those of 
TCSs. However, in the 90's the first prokaryotic Ser/Thr kinase was discovered in 
Myxocuccus xanthus (Munoz-Dorado et al., 1991; Zhang et al., 1992). In the following 
two decades it became obvious that Ser/Thr kinases are key players in bacterial signal 
transduction, and was summarized well by the title: "No longer an exclusive club: 
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eukaryotic signalling domains in bacteria" (Bakal and Davies, 2000), which also happens 
to be an excellent review paper. For an up-to-date review the reader is advised to consult 
the following papers (Burnside and Rajagopal, 2012; Pereira et al., 2011). A recent 
Global Ocean Sampling dataset, led by the J. Craig Venter, reveled that Ser/Thr kinases 
are just as ubiquitous as histidine kinases and may be equally important in regulating 
prokaryotic behavior (Kannan et al., 2007). 
1.5.1 S. aureus Ser/Thr Kinase and Phosphatase 
The S. aureus genome contains one major Ser/Thr kinase and phosphatase, termed 
Stkl and Stpl, respectively. These proteins are cotranscribed and thus work together to 
regulate substrates (Beltramini et al., 2009). It should be noted that a subset of MRSA 
strains, such as MU50, MW2 and N315, contain a soluble Ser/Thr kinase, termed Stk2. 
To date the function of Stk2 is unknown. Stkl is a transmembrane protein that contains 
three repeating Q_enicillin-binding protein ~d ~erine/!hreonine kinase ~ssociated domains 
(PASTA) at the extracellular surface and a cytoplasmic kinase domain (A schematic is 
presented in Section 2.1, Fig. 2.1.1 ). The intracellular kinase domain belongs to the 
Hanks-type structural family of kinases first descried in eukaryotes (Hanks et al., 1988), 
which is why prokaryotic STKs are sometimes referred to as "eukaryotic-like." The 
structure of the Stkl kinase domain was recently solved, unfortunately the protein 
crystalized in an inactive form, autoinhibited state (Rakette et al., 2012). The three-
dimensional structure of the PASTA domains was also solved (Paracuellos et al., 201 O; 
Ruggiero et al., 2011) and studies suggest these domains may bind PG (Shah et al., 2008; 
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Squeglia et al., 2011). 
It is yet unknown which molecules activate Stkl and whether these interactions 
facilitate autophosphorylation. However, in B. subtilis it was demonstrated PrkC, a 
homologue of Stkl, contains an arginine residue in the PAST A domain capable of 
interacting with the negatively charged meso-diaminopimelic acid (DAP) side chain of 
PG (Squeglia et al., 2011 ). The PG of S. aureus is Lys-type, and is unable to bind to the 
PrkC PASTA domain, vice versa the DAP-type PG cannot bind Stkl PASTA domain 
(Shah et al., 2008). It is suggested that throughout bacterial evolution and divergence the 
STK proteins were conserved but acquired new roles depending on, for example, the 
physical environment or niche the organism inhabited. 
Although the stimuli sensed by Stkl are almost completely unknown, a number of 
phosphorylation targets have been identified. Known substrates of Stkl to date include 
SarA (Didier et al., 2010; Sun· et al., 2012), MgrA (Truong-Bolduc et al., 2008), LuxS 
(Cluzel et al., 2010), PurA (Donat et al., 2009), CcpA (Leiba et al., 2012), enzymes of the 
central metabolism (Lomas-Lopez et al., 2007) and a human transcription factor (Miller et 
al., 2010). Along with in vivo studies Stkl/Stpl are suggested to be important in growth, 
virulence, antibiotic resistance and secondary metabolite production through the 
phosphorylation of the above-mentioned, and yet to be determined, substrates. This 
central role makes Stkl a suitable target for future drug development. 
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1.6 Aims of this work 
In the context of human health pathogenic bacteria with antibiotic resistance are a 
public threat. There is a challenge to develop safe drugs that target bacterial pathways and 
not those of the host organism. Therefore identifying targets such as Stk 1, and 
understanding their biological roles, is essential for the development of novel antibacterial 
molecules. Whether these are essential targets of the bacteria or not, the combination of a 
number of drugs can act synergistically to decrease virulence and fundamental processes 
with a lower chance of developing resistance. 
Hence the aim of this work was to biochemically characterize Stk 1 and its cognate 
Stp 1 partner in vitro with an emphasis on discovering novel phosphorylation targets. The 
second part focused on translating our findings in vivo. The third part of this work 
questions whether GraR-regulated genes are solely responsible for antimicrobial peptide 
resistance, or whether these genes are simply required for proper cell function and as a 
byproduct are able to confer resistance? For example, GraSR regulates many genes, some 
of which make the overall surface charge positive. But is positive surface charge only 
elicited in the presence of antimicrobial peptides or is surface charge an intrinsic 
mechanism that governs the normal activity of proteins and other factors? It will be 
argued that GraSR in fact plays a global role in the cell, and some of the genes previously 
believed to be responsible for antimicrobial peptide resistance are required under non-
stress conditions for proper cell function. 
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CHAPTER TWO 
IN VITRO CHARACTERIZATION OF THE S. AUREUS STKl/STPl 
PROTEINS AND THEIR POTENTIAL TARGETS 
2.1 Introduction 
Bacterial survival hinges on the ability to coordinate gene expression at 
appropriate times throughout its life cycle. Furthermore, the ability to sense and respond 
to external cues, such as natural perturbations in the cell wall or antibiotic stress, is 
equally important. In S. aureus, and other prokaryotic organisms, this coordination has 
been attributed to pairs of proteins commonly referred to as a two-component system 
(TCS). 
There have been 16 TCSs systems identified in the S. aureus genome (Ito et al., 
1999; Kuroda et al., 2001). Briefly, a TCS is composed of a histidine kinase, a 
cytoplasmic membrane protein that undergoes autophosphory lation (at a histidine 
residue) following a stimulus and a response regulator, typically a transcription factor, 
which gets phosphorylated (at an aspartic acid residue) to ultimately control gene 
expression (Chang and Stewart, 1998; Laub and Goulian, 2007; Stock et al., 2000). In S. 
aureus these systems have been found to be involved in a number of biological processes 
such as, but not limited to, autolysis (Brunskill and Bayles, 1996), production of toxins 
and virulence factors (Ventura et al., 2010; Yarwood et al., 2001), biofilm formation 
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(Sharma-Kuinkel et al., 2009), cell wall synthesis (Belcheva and Golemi-Kotra, 2008; 
Kuroda et al., 2004) and resistance to antimicrobial peptides (Falord et al., 2012; Yang et 
al., 2012). 
In light of these findings, a growing body of literature supports another post-
translational modification involving serine/threonine, and to a lesser extant tyrosine 
phosphorylation (Bakal and Davies, 2000; Munoz-Dorado et al., 1991; Zhang et al., 
1992). The discovery of serine/threonine kinases (STK) and phosphatases (STP) has 
diversified our understanding of how cells sense and coordinate gene expression. 
Prokaryotic STKs and STPs, much like TCS, are linked to many processes such as 
sporulation (Shah et al., 2008), antibiotic resistance (Tamber et al., 2010), biofilm 
formation (Liu et al., 2011) and virulence (Cheung and Duclos, 2012). 
The S. aureus MU50 genome contains two highly conserved genes, savl 219 and 
sav1220, designated Stpl (744bp/247aa) and Stkl (1995bp/664aa), respectively. Other 
aliases of the Stkl protein in the literature include PknB and PrkC, but it will be referred 
to as Stkl in this study. The domain organization of these proteins is presented in Fig. 
2.1.1. The N-terminal, or catalytic region, of Stkl is cytoplasmic and harbors the 
regulatory elements involved in activation and specificity of the protein. The catalytic 
region is attached to a single a-helix which transverses the cytoplasmic membrane and 
connects to three extracellular penicillin-binding protein and serine/threonine kinase 
associated domains (PASTA). The Stpl protein is a cytoplasmic protein. 
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Stpl 
PASTA-3 { 
(445-510) 
Stkl 
} 
PASTA-2 
(380-440) 
N-terminal 
Figure 2.1.1 Domain organization of Stkl and Stpl 
Catalytic 
region 
( 1-282) 
The kinase, Stkl (shown in blue), contains a cytoplasmic catalytic (N-terminal) region 
connected to three extracellular PAST A domains by a single transmembrane a-helix. The 
phosphatase, Stpl (shown in orange), is a cytoplasmic protein. Stpl depicted as M 
' tuberculosis PP2C-Family Ser/Thr Protein Phosphatase (retrieved from Protein Data 
Bank (PDB) with accession code: 1 TXO (Pullen et al., 2004)) and Stkl constructed from 
accession codes: 4EQM (Rakette et al., 2012) and 3M9G (Paracuellos et al., 2010). 
Figure prepared using UCSF Chimera 1.8 and Photoshop/Illustrator CS6 (Adobe®). 
The precise role of Stkl, and its cotranscribing Stpl, has not been established 
given the varying functions these proteins appear to be involved in. Early studies 
demonstrated that Stkl and Stpl are involved in proper cell wall architecture and 
antimicrobial resistance (Beltramini et al., 2009), as well as carbohydrate metabolism 
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(Lomas-Lopez et al., 2007) and efflux pump regulation (Truong-Bolduc et al., 2008). 
However, subsequent work suggested a more diverse role for Stkl/Stpl system as a result 
of a transcriptome analysis on S. aureus Stkl knockout (i1Stkl) strain that revealed high 
regulatory impacts on a large variety of genes (Donat et al., 2009). 
The above-mentioned studies probing Stkl function were predominantly in vivo 
. based. These studies established important phenotypes of i1Stk 1 and/ or i1Stp 1, but failed 
to demonstrate the molecular mechanism by which Stkl exerts its function. Put 
differently, Stkl is a kinase protein that does not directly regulate genes, but does so via 
phosphorylation of substrates that themselves are directly or indirectly involved in gene 
regulation. The identification of substrates Stkl phosphorylates aids in bridging the gap 
between observed i1Stk 1 phenotypes and molecular mechanisms governing these 
phenotypes. 
To date, studies have reported that Stkl is capable of phosphorylating the 
substrates SarA (Didier et al., 2010; Sun et al., 2012), MgrA (Truong-Bolduc et al., 
2008), LuxS (Cluzel et al., 2010), PurA (Donat et al., 2009), CcpA (Leiba et al., 2012), 
enzymes of the central metabolism (Lomas-Lopez et al., 2007) and a human transcription 
factor (Miller et al., 2010). For the purpose of this study, it is irrelevant to understand in 
detail the roles of these enzymes, however, one should appreciate the diversity of proteins 
that are phosphorylated by Stkl. Hence the study herein aims to further investigate the 
functional role of Stkl/Stpl in vitro, with an emphasis on discovering new 
phosphorylation targets of Stk 1. 
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2.2 Materials and Methods 
2.2.1 Materials and chemicals 
The Champion pET Directional TOPO Expression Kit was purchased from 
Invitrogen. Chemicals and growth media were purchased from Sigma (Oakville, Canada) 
or Thermo-Fisher (Whitby, Canada), unless otherwise stated. All resins for purification 
were purchased from Qiagen or GE Healthcare (Quebec, Canada). All primers were 
purchased from Sigma (Oakville, Canada). Cold ATP and restriction enzymes were 
purchased from New England Biolabs (Pickering, Canada). The DNA polymerases 
PfuTurbo® and Phusion® High-fidelity were purchased from Agilent Technologies and 
Thermo-Fisher (Whitby, Canada), respectively. Radioactive y-32P-ATP with specificity of 
10 Ci/mmol was purchased from PerkinElmer LAS Canada Inc. (Toronto, Canada). The 
Trypsin Profile IGD kit was obtained from Sigma-Aldrich. 
2.2.2 Expression and purification of His-Stkl 
The savl 220 gene, Stkl, was amplified from S. aureus MU50 genome and 
cloned directly into pET151/D-TOPO with primer set Dir 5'- CACCATGATAGGTAAA 
ATAATAAATGAAC and Rev 5'- TTATTAAATATCATCATAGCTGACTTC. The 
6xHis tag is located on the N-terminal of the protein. The resulting plasmid was used to 
transform NovaBlue cells, which were sequenced (T7 and T7term primers) for the correct 
insert (York University, Department of Biology, Core Facility). The plasmid was 
ultimately transformed into BL21(DE3) cells. 
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A 1 mL overnight seed culture of E. coli BL21(DE3) containing pET151/D-
TOPO-His-Stkl was used to inoculate 800 mL of Terrific Broth medium supplemented 
with ampicillin (100 µg/mL). The inoculated medium was grown at 37°C, 200 rpm, until 
OD600 reached 0.6-0.8, at which time protein expression was induced by addition of 
Isopropyl B-0 -thiogalactopyranoside (IPTG) at a final concentration of 1 mM for 18 hours 
at 10°C, 100 rpm. Cells were harvested at 8, 230 xg for 15 min at 4 °C. Resulting pellets, 
aliquoted to 1.5 g, were frozen at -80°C if subsequent purification steps were not carried 
out on same day. All parts of the purification protocol were carried out at 4 °C on a fast 
protein liquid chromatography (FPLC) instrument (Amersham Biosciences). Harvested 
pellets were resuspended in 10 mL of 50 mM NaP04, 300 mM NaCl, and 10 mM 
imidazole, pH 7.5 containing Triton-XIOO (0.5% final). Sonication (3 min of 20 sec on, 
20 off; 20% amplitude) was used to liberate the protein and centrifugation at 18,138 xg 
for 60 min was carried out to rid of cell debris. Supernatant was loaded onto a 5 mL Ni-
NTA self-packed column (Generon). Elution was carried out at 3 mL/min with a step 
gradient of 10%, 30%, 50% and 100% elution buffer (50 mM NaP04, 300 mM NaCl, and 
300 mM imidazole, pH 7.5) and 10 mL fractions were collected. Fractions containing 
protein of interest were pooled and concentrated using centrifugal filter Ultracel-30K 
(Amicon, Millipore). Protein homogeneity was assessed using 12.5% SDS-PAGE and 
stained with Coomassie Blue. 
2.2.3 Expression and purification of Stpl 
The sav1219 gene, Stpl, was amplified from S. aureus MU50 genome and 
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cloned into pET26b(+) with primer set Dir 5'- GGAATTCCATATGCTAGAGG 
CACAATTTTTTAC and Rev 5'-AAGGAATTCCTCATCATCATACTTTATCA 
CCTTCAATAG. Restriction cut sites Ndel (Dir primer) and EcoRI (Rev primer) are 
underlined. The resulting plasmid was used to transform NovaBlue cells, which were 
sequenced (T7 and T7term) for the correct insert (York University, Department of 
Biology, Core Facility). The plasmid was ultimately transformed into BL2l(DE3) cells. 
A 1 mL overnight seed culture of E. coli BL21(DE3) containing pET26b(+)-Stpl 
was used to inoculate 800 mL of Terrific Broth medium supplemented with kanamycin 
(30 µg/mL ). The inoculated medium was grown at 3 7°C, 200 rpm, until OD6oo reached 
0.6-0.8, at which time protein expression was induced by addition of IPTG at a final 
concentration of 0.5 mM. Expression was carried out for 12 hours at 25°C, 120 rpm. Cells 
were harvested at 8, 230 xg for 15 min at 4°C. Resulting pellets, aliquoted to 3 g, were 
frozen at -80°C if subsequent purification steps were not carried out on same day. All 
parts of the purification protocol were carried out at 4°C by FPLC. Harvested pellets were· 
resuspended in loading buffer (20 mM Tris buffer, pH 7 .0, supplemented with 5 mM 
MgCh). Sonication (3 min of 30 sec on, 30 off; 20% amplitude) was used to liberate the 
protein and centrifugation at 18,138 xg for 60 min was carried out to remove cell debris. 
The resulting supernatant was applied to a DEAE cellulose-Sepharose Fast Flow self-
packed column (Econo-Column, 2.5 x 20 cm, 80 mL column volume, Bio-Rad) pre-
equilibrated in loading buffer. Elution was carried out at 4 mL/min with a 480 mL linear 
gradient from loading buffer to elution buffer (500 mM Tris buffer, pH 7.0, 5 mM 
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MgCb), and 10 mL fractions were collected. Fractions containing protein of interest were 
pooled and concentrated using centrifugal filter Ultracel-1 OK (Amicon, Millipore). The 
concentrated sample was re-applied to a similar DEAE cellulose-Sepharose Fast Flow 
self-packed column (C column 16/20, 40 mL column volumes, GE Healthcare). Fractions 
containing protein of interest were pooled and concentrated using new centrifugal filter 
Ultracel-1 OK (Amicon, Millipore). Protein homogeneity was assessed using a 15% SDS-
PAGE and stained with Coomassie Blue. 
2.2.4 Purification of GraR, BceR, VraR, WalR, FmtA, PBP4 and PBP2a 
All proteins were purified by FPLC at 4 °C. The purification of BceR and WalR 
was similar to previously described VraR protein (Belcheva and Golemi-Kotra, 2008). 
GraR was purified similarly with minor modifications. Briefly, for the final polishing step 
the GraR protein was passed through a HiPrep 26/60 Sephacryl S-200 HR size exclusion 
column (GE Healthcare). PBP4 was purified similarly to previously described FmtA 
protein (Fan et al., 2007). PBP2a was purified by passing supernatant through Q-
Sepharose column; the fractions containing protein of interest were collected, desalted 
and further passed through S-Support column. 
2.2.5 His-Stkl identification by mass spectrometry 
His-Stkl (10 µM) was separated by 12.5% SDS-PAGE and stained with 
Coomassie Blue; the band of interest was cut from the gel and an in-gel tryptic digestion 
was carried out with the Trypsin Profile IGD Kit (Sigma Aldrich). The sample was 
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analyzed by liquid chromatography-mass spectrometry (LC-MS/MS) at the Advanced 
Protein Technology Centre, The Hospital for Sick Children (Toronto, Canada). 
2.2.6 His-Stkl phosphorylation assays 
2.2.6.1 Autophosphorylation of His-Stkl 
His-Stkl (2 µM) was incubated with 20 µM [y-32P]-ATP (10 Ci/mmol) in 
phosphorylation buffer (PB), 25 mM Tris-HCI (pH 7.5), 1 mM DTT, and 10 mM MgCh 
at room temperature. The reactions were quenched at various time inte,rvals by the 
addition of 5x SDS Gel-loading buffer. Quenched reactions were separated by 12.5% 
SDS-PAGE. Radioactive SDS-PAGE gel was exposed to autoradiography cassette, which 
was scanned using TYPHOON Trio+ (GE Healthcare), and then stained by Coomassie 
blue. 
2.2.6.2 Effects of divalent ions on the autophosphorylation of His-Stkl 
His-Stkl (5 µM) was incubated with 20 µM [y-32P]-ATP (10 Ci/mmol) in 25 
mM Tris-HCI, pH 7.5, 1 mM DTT and varying concentrations of either MgCh or MnCh 
for 30 min at room temperature. The reactions were quenched with 5x SDS Gel-loading 
buffer and separated by 12.5% SDS-PAGE. Radioactive SDS-PAGE gel was exposed to 
autoradiography cassette, which was scanned using TYPHOON Trio+ (GE Healthcare), 
and then stained by Coomassie blue. 
2.2.6.3 Stability of His-Stkl following autophosphorylation 
His-Stkl (20 µM) was autophosphorylated with 20 µM [y-32P]-ATP (10 
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Ci/mmol) in PB, described above, for 30 min. The master mixture was desalted to remove 
excess [y-32P]-ATP with desalting column (Pierce Zeba™, Thermo Scientific) and further 
incubated at room temperature. Sample was removed from master mixture at defined time 
intervals and quenched with 5x SDS Gel-loading buffer. Quenched reactions were 
separated by 12.5% SDS-PAGE. Radioactive SDS-PAGE gel was exposed to 
autoradiography cassette, which was scanned using TYPHOON Trio+ (GE Healthcare). 
2.2. 7 Dephosphorylation of His-Stkl by Stpl 
His-Stkl (25 µM) was autophosphorylated, as in section 2.2.6.2, either on its 
own or in the presence of Stpl (20 µM) for 30 min at room temperature. Reactions were 
quenched with 5x SDS Gel-loading buffer and separated by 12.5% SDS-PAGE. 
Radioactive SDS-PAGE gel was exposed to autoradiography cassette, which was scanned 
using TYPHOON Trio+ (GE Healthcare), and then stained by Coomassie blue. 
2.2.8 Phosphorylation of potential His-Stkl substrates 
2.2.8.1 Probing phosphorylation of response regulators 
His-Stkl (5 µM) was incubated with the response regulators GraR (10 µM), 
BceR (10 µM), VraR (20 µM) and WalR (10 µM) with 20 µM [y-32P]-ATP (10 Ci/mmol) 
in PB at room temperature for 30 min. Proteins were separated by 15% SDS-PAGE, 
exposed to autoradiography cassette, which was scanned using TYPHOON Trio+ (GE 
Healthcare), and then stained by Coomassie blue. 
42 
2.2.8.2 Probing phosphorylation of penicillin-binding proteins 
His-Stkl (10 µM) was incubated with the penicillin-binding proteins PBP2a (10 
µM), PBP4 (20 µM) and FmtA (20 µM) with 20 µM [y-32P]-ATP (10 Ci/mmol) in PB at 
room temperature for 30 min. GraR (10 µM) was used as a control and phosphorylated 
under same conditions. Proteins were separated by 12.5% SDS-PAGE, exposed to 
autoradiography cassette, which was scanned using TYPHOON Trio+ (GE Healthcare), 
and then stained by Coomassie blue. 
2.2.9 Assessing phosphorylation of FmtA by His-Stkl with acidic-nativ1e PAGE 
His-Stkl (10 µM) was incubated with FmtA (20 µM), PBP4 (20 µM) and GraR 
(10 µM) with 20 µM [y-32P]-ATP (10 Ci/mmol) in PB at both room temperature and 37°C 
for 30 min. Proteins were separated by 10% acidic-native PAGE, exposed to 
autoradiography cassette, which was scanned using TYPHOON Trio+ (GE Healthcare), 
and then stained by Coomassie blue. 
2.2.10 Closer examination of GraR phosphorylation by His-Stkl 
2.2.10.1 Time-dependent phosphorylation of GraR by His-Stkl 
A master mixture containing His-Stkl (5 µM), GraR (10 µM) and 20 µM [y-
32P]-ATP (10 Ci/mmol) in PB was incubated at room temperature. Aliquots of 15 µL 
were removed and quenched at various time intervals by the addition of 5x SDS Gel-
loading buffer. Quenched reactions were separated by 15% SDS-PAGE. Radioactive 
SDS-PAGE gel was exposed to autoradiography cassette, which was scanned using 
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TYPHOON Trio+ (GE Healthcare), and then stained by Coomassie blue. 
2.2.10.2 Phosphorylation of denatured GraR by His-Stkl 
His-Stkl (5 µM) and GraR (25 µM) were incubated with 20 µM [y-32P]-ATP (10 
Ci/mmol) in PB at room temperature for 30 min either together or separately. In a 
separate reaction proteins were first denatured by boiling for 10 min and subsequently 
phosphorylated under same conditions. Reactions were separated by 15% SDS-PAGE. 
Radioactive SDS-PAGE gel was exposed to autoradiography cassette, which was scanned 
using TYPHOON Trio+ (GE Healthcare), and then stained by Coomassie blue. 
2.2.10.3 Quantifying phosphorylated GraR by Phos-tag PAGE 
His-Stkl (5 µM) and GraR (either 5 or 10 µM) were incubated with 20 µM [y-
32P]-ATP (10 Ci/mmol) in PB at 37°C for 30 min. Reactions were quenched and loaded 
to 12% SDS-PAGE and 12% phos-tag PAGE. The phos-tag PAGE method is described in 
detail (Kinoshita and Kinoshita-Kikuta, 2011; Kinoshita et al., 2006). Briefly, the gel 
contained 100 µM Mn2+-phos-tag in 12% acrylamide (made from 30% acrylamide, 0.8% 
bis-acrylamide stock). No SDS was added to the gel. Electrophoresis was carried out in a 
manner identical to the traditional SDS-PAGE. Radioactive gels were exposed to 
autoradiography cassette, which were scanned using TYPHOON Trio+ (GE Healthcare), 
and stained by Coomassie blue. 
2.2.10.4 Dephosphorylation of GraR by Stpl 
Phosphorylation of GraR (10 µM) was carried by the addition of His-Stkl (5 
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µM) with 20 µM [y-32P]-ATP (10 Ci/rnmol) in PB at room temperature for 30 min. 
Subsequently, Stpl (20 µM) was added and the reaction proceeded for 30 min more. 
Reactions were separated by 15% SDS-PAGE. The gel was exposed to autoradiography 
cassette, which was scanned using TYPHOON Trio+ (GE Healthcare), and then stained 
by Coomassie blue. 
2.2.11 Investigating the Stkl-mediated phosphorylation sites of GraR 
2.2.11.1 Phosphorylation of GraRc and GraRN 
His-Stkl (5 µM) was incubated with 20 µM of GraR C-terminal (GraRc) or 
GraR-N terminal (GraRN) with 20 µM [y-32P]-ATP (10 Ci/rnmol) in PB at room 
temperature for 30 min. GarRc was separated with 15% SDS-PAGE. GarRN was 
separated with 12.5% SDS-PAGE. Both gels were exposed to autoradiography cassette, 
which was scanned using TYPHOON Trio+ (GE Healthcare). Only GarRN gel was stained 
with Coomassie blue. 
2.2.11.2 Identification of phosphorylated GraR sites by mass spectrometry 
Phosphorylation of GraR full length ( 40 µM) or GraRc ( 40 µM) was achieved by 
incubating with His-Stkl (20 µM) in presence of cold ATP (500 µM) in PB at room 
temperature for 60 min. As a control, GraR proteins and His-Stkl were incubated 
together under same conditions without cold ATP. Following phosphorylation GraR full 
length was directly digested with trypsin (Promega) overnight at 37°C in 100 mM 
ammonium bicarbonate, whereas GraR-C terminal was separated by 15% SDS-PAGE. 
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The gel was stained with Coomassie Blue; the band of interest was cut from the gel and 
an in-gel tryptic digestion was carried out with the Trypsin Profile IGD Kit (Sigma 
Aldrich). The full length GraR was analyzed by liquid chromatography-mass 
spectrometry (LC-MS/MS) at the Centre for Research in Mass Spectrometry, York 
University (Toronto, Canada). The GraR-C terminal was analyzed by liquid 
chromatography-mass spectrometry (LC-MS/MS) at the Advanced Protein Technology 
Centre, The Hospital for Sick Children (Toronto, Canada). 
2.2.11.3 Site-directed mutagenesis of GraR phosphorylation sites 
The pET26b: :graR contrast was previously prepared in the laboratory. 
pET26b: :graR mutants harboring threonine to alanine substitutions at Thr 128 (encoded 
by ACA) , Thrl30 (encoded by ACT), Thr149 (encoded by ACG) and a triple mutant 
containing all three mutations were generated with the QuikChange™ Site-Directed 
Mutagenesis method (Stratagene ). Alanine substitutions are highlighted in bold within the 
PCR primers. The GraR-T128A mutant was generated with PCR primers Dir 5'-
CTGAAGAAAAACGTGCATTGACTTGGCAAG and Rev 5'- CTTGCCAAGTCAA 
TGCACGTTTTTCTTCAG. The GraR-Tl30A mutant was generated with PCR primers 
Dir 5'- GAAAAACGTACATTGGCTTGGCAAGATGC and Rev 5'- GCATCTTGCCA 
AGCCAATGTACGTTTTTC. The GraR-Tl49A mutant was generated with PCR 
primers Dir 5'-CAAAAAGGTGACGATGCGATTTTTCTATCC and Rev 5'-
GGATAGAAAAATCGCATCGTCACCTTTTTG. The GraR triple mutant was first 
generated with Dir 5'- GAAAAACGTGCATTGGCTTGGCAAGATGC and Rev 5'-
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GCATCTTGCCAAGCCAATGCACGTTTTTC to yield GraR-T128A/T130A, which 
was further mutated with the same primers used for GraR-T149A to yield GraR-
T128A/T130A/T149A. 
Following PCR amplification the products were digested with restriction 
endonuclease Dpnl to remove original methylated template DNA. Subsequently, E. coli 
NovaBlue cells were transformed with the Dpnl-digested reactions. Correct mutagenesis 
was confirmed by DNA sequencing (York University, Department of Biology, Core 
Facility). The resulting constructs were transformed into E. coli BL21(DE3) cells. 
Expression and purification for GraR single mutants was carried out as previously 
described for GraR wild-type. 
2.2.11.4 Phosphorylation of GraR-T128A, GraR-T130A and GraR-T149A by His-
Stkl 
His-Stkl (5 µM) was incubated with GraR-WT (25 µM), GraR-T128A (25 µM), 
GraR-Tl30A (10 µM) and GraR-T149A (25 µM) with 20 µM [y-32P]-ATP (10 Ci/mmol) 
in PB at room temperature for 30 min. Proteins were separated by 15% SDS-PAGE, 
exposed to autoradiography cassette, which was scanned using TYPHOON Trio+ (GE 
Healthcare), and then stained by Coomassie blue. 
2.2.11.5 Expression of GraR triple mutant (Tl28A/T130A/T149A) 
A 1 mL overnight seed culture of E. coli BL21(DE3) containing pET26b(+)-
GraR-T128A/T130A/T149A was used to inoculate 800 mL of Terrific Broth medium 
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supplemented with kanamycin (30 µg/mL). The inoculated medium was grnwn at 37°C, 
200 rpm, until OD6oo reached 0.6-0.8. Protein expression was induced by addition of 
IPTG at concentrations of 0.1 or 0.5 mM. Expression was carried out for 12-18 hours at 
25°C or 18°C, 120 rpm. Expression tests were separated by 15% SDS-PAGE and stained 
with Coomassie blue. 
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2.3 Results 
2.3.1 Expression and purification of His-Stkl 
The pET151/D-TOPO-His-Stkl construct, transformed into E. coli BL21(DE3) 
cells, contains an inducible T7 promoter. Following induction with IPTG sufficient 
amount of soluble His-Stk 1 was obtained, as seen in Fig. 2.3 .1, for subsequent 
purification steps. 
75 kDa ~ His-Stkl 
25 kDa ~ Stpl 
Figure 2.3.1 Expression of Stpl and His-Stkl recombinant proteins in BL2l(DE3) 
Expression profile of target proteins analyzed by 15% SDS-polyacrylamide gel, stained 
with Coomassie blue. Expression of His-Stkl achieved by addition of 1 mM IPTG for 18 
hours at 10 °C. For Stpl expression, 0.5 mM IPTG added for 16 hours at 25°C. 
The theoretical pl of His-Stkl was calculated to be 5.76 with a calculated 
molecular weight of 74,377 Da. The calculated molecular weight of the recombinant 
protein is 78,160 Da and a pl of 5.85 due to the 6xHis-V5 epitope-TEV sequence at the 
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N-terminus of the protein. His-Stkl contains a 6xHis tag and to facilitate protein 
purification the supernatant was passed through a Ni-NTA column connected to an FPLC 
system. The protein was eluted with step gradients of increasing imidazole 
concentrations, Fig. 2.3.2A, and protein purity was assessed during purification (Fig. 
2.3.2B) and following concentration (Fig. 2.3.2C). Typically 1-1.5 mg of His-Stkl would 
be obtained from a 1.5 g cell pellet. 
A) 
* 
Fractions 
B) 2 3 13 14 15 18 19 C) 
~His-Stkl 
Figure 2.3.2 Purification chromatogram of His-Stkl following Ni-NT A column 
analyzed by SDS-PAGE 
A) FPLC chromatogram following elution from a Ni-NT A column. Protein elution 
indicated with asterisk. On chromatogram blue line represents UV at 280nm, green is 
concentration and in red are the fractions B) A 12.5% SDS-PAGE was loaded with 
fractions from Ni-NT A column. C) Pure His-Stkl following concentration separated by 
12.5% SDS-PAGE. Gels were stained with Coomassie blue to detect proteins. 
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Although the protein gets expressed, the amount of expression is much lower 
than typical expression systems or compared to Stp 1 (Figure 2.3 .1 ). Thus to confirm 
successful His-Stkl, following purification and separation by SDS-PAGE, the band of 
interest was cut out and sent for analysis by liquid chromatography-mass spectrometry 
(LC-MS/MS). Data in Appendix A confirms that the band of interest is indeed His-Stkl. 
2.3.2 Expression and purification of Stpl 
The pET26b(+)-Stpl construct, transformed into E. coli BL21(DE3) cells, 
contains an inducible T7 promoter. Following induction with IPTG sufficient amount of 
soluble Stpl was obtained, Fig. 2.3.1, for subsequent purification steps. The theoretical pl 
of Stpl was calculated to be 5.02 with a molecular weight of 27,916 Da (minus first 
methionine). The purification strategy involved passing the supernatant through a DEAE 
cellulose-Sepharose column (anion exchange) (Fig. 2.3.3A). The resulting fractions, 
despite being adequately pure as assessed by 15% SDS-PAGE (Fig. 2.3.3B), were pooled 
together and passed through a smaller DEAE cellulose-Sepharose column (Fig. 2.3.3C). 
Resulting fractions (Fig. 2.3.3D) were concentrated and final protein homogeneity (Fig 
2.3.3E) was assessed by 15% SDS-PAGE. Typically 20-25 mg of Stpl was obtained from 
a 2.5 g pellet. 
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Figure 2.3.3 Purification chromatograms of Stpl following DEAE columns analyzed 
by SDS-PAGE 
A) FPLC chromatogram following elution from 80 mL DEAE column. B) A 15% SDS-
PAGE gel was loaded with fractions from 80 mL DEAE column. C) FPLC chromatogram 
following elution from 40 mL DEAE column.D) A 15% SDS-PAGE gel was loaded with 
fractions from 40 mL DEAE column. E) A 12.5% SDS-PAGE gel was loaded with pure 
Stp 1. Gels were stained with Coomassie blue to detect proteins. Markers in each figure 
coincide with same gel, but different lanes. Protein elutions indicated with asterisks. On 
chromatograms blue line represents UV at 280nm, green is concentration, teal is 
conductivity and in red are the fractions. 
2.3.3 Enzymatic activity of His-Stkl and Stpl in vitro 
To examine the importance of Stkl and Stpl it was necessary to establish that 
purified recombinant proteins were enzymatically active in vitro. This was carried out 
52 
with phosphorylation assays involving radioactive ATP. His-Stk 1, in the presence of [ y-
32P]-ATP undergoes autophosphorylation in a time-dependent manner (Fig. 2.3.4A), 
where the majority of the kinase is phosphorylated within the first 30 min. 
Autophosphorylation of His-Stkl was achieved with either Mg2+ or Mn2+ as 
cofactors (Fig. 2.3.4B). Although this experiment revealed that at higher concentrations 
of Mn2+ less phosphorylation is achieved, as observed by the decrease in signal. 
A) Time (min) 
0.25 0.5 1 2 3 5 10 30 60 
Coomassie 
~ ---Radioactive 
B) Mg2+ Mn2+ 
2.5 5 10 20 2.5 5 10 20 mM 
Coomassie 
--Radioactive 
C) Time (min) 
1 5 10 30 
lllllHis-Stkl 
Radioactive 
Figure 2.3.4 Enzymatic activity of His-Stkl in vitro 
A) Autophosphorylation of His-Stkl. His-Stkl (2 µM) was incubated with 
[y-32P]- ATP (20 µM) at various time intervals in PB at room temperature. Both images 
are of same gel. B) His-Stkl (5 µM) was incubated with [y-32P]-ATP (20 µM) in 25 mM 
Tris-HCl, pH 7.5, 1 mM DTT and varying concentrations of either MgCh or MnCh for 
30 min at room temperature. Reactions were quenched with 5x SDS Gel-loading buffer. 
Both images are of same gel. C) His-Stkl (20 µM) was autophosphorylated, desalted and 
further incubated at room temperature. Reactions were quenched at indicated time 
intervals. All reactions resolved with 12.5% SDS-PAGE, exposed to autoradiography 
cassette, scanned using TYPHOON Trio+ (GE Healthcare). A) and B) were subsequently 
stained with Coomassie blue. 
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Following autophosphorylation, and the removal of excess ATP by desalting, it 
was observed that His-Stkl signal was stable for at least 30 min at room temperature (Fig. 
2.3 .4C). This prompted the investigation of the phosphatase activity of Stp 1 towards 
phosphorylated His-Stkl. The results demonstrate that addition of Stpl to an already 
phosphorylated His-Stkl completely removes the signal (Fig. 2.3.5). 
Coomassie 
Radioactive 
Figure 2.3.5 Phosphatase activity of Stpl towards phosphorylated His-Stkl 
His-Stkl (5 µM) was autophosphorylated with [y-32P]- ATP (20 µM) for 30 min in PB at 
room temperature. Stp 1 (20 µM) was added to the mixture and further incubated for 30 
min at room temperature. Reactions were quenched and resolved by 12.5% SDS-PAGE. 
The gel was exposed to an autoradiography cassette, which was scanned using 
TYPHOON Trio+ (GE Healthcare) and subsequently stained with Coomassie blue. 
2.3.4 Phosphorylation of potential S. aureus substrates by His-Stkl in vitro 
The ultimate goal of this study was to discover novel substrates of His-Stkl and 
its cognate Stp 1. Both proteins were established to be active in vitro, hence we moved on 
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to probing interaction with various proteins. Previous research has recognized that Stkl is 
capable ofphosphorylating global regulators of S. aureus. To determine whether His-Stkl 
can phosphorylate response regulators belonging to TCS, we carried out in vitro kinase 
assays. As shown in Fig. 2.3.6, His-Stkl is capable of phosphorylating GraR and unable 
to phosphorylate V raR, BceR or W alR. 
His-Stkl • 
WalR• 
BceR• 
VraR• 
Coomassie Radioactive 
Figure 2.3.6 His-Stkl phosphorylation of response regulators 
4GraR 
His-Stkl (5 µM) was incubated with the response regulators WalR (10 µM), VraR (20 
µM), BceR (10 µM) and GarR (lOµM) for 30 min in PB at room temperature in the 
presence of [y-32P]- ATP (20 µM). Reactions were quenched and resolved by 15% SDS-
p AGE. The gel was exposed to an autoradiography cassette, which was scanned using 
TYPHOON Trio+ (GE Healthcare) and subsequently stained with Coomassie blue. 
The observation that His-Stkl was capable of specifically phosphorylating GraR 
in vitro prompted us to investigate whether other proteins, such as penicillin binding 
proteins, were capable of undergoing phosphorylation by His-Stkl. In this experiment 
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PBP2a, PBP4 and FmtA were incubated with and without His-Stkl in the presence of [y-
32P]- ATP. The GraR protein was used as a control. Under the conditions tested, the 
results demonstrate His-Stkl is unabale to phosphorylate PBP2a or PBP4, however a faint 
band was observed for FmtA (Fig. 2.3. 7). 
PBP4• 4FmtA 
4GraR 
Coomassie 
Radioactive 
Figure 2.3. 7 His-Stkl phosphorylation of penicillin-binding proteins 
The penicillin-binding proteins PBP2a (10 µM), PBP4 (20 µM) and FmtA (20 µM) were 
incubated either alone or with His-Stk 1 (10 µM) in the presence of [ y-32P]- ATP (20 µM) 
in PB for 30 min at room temeperature. GraR (10 µM) was used as control and subjected 
to same conditions Reactions were resolved by 12.5% SDS-PAGE. The gel was exposed 
to an autoradiography cassette, which was scanned using TYPHOON Trio+ (GE 
Healthcare) and subsequently stained with Coomassie blue. 
As can be seen in the coomassie gel the FmtA protein does not form a single 
crisp band but forms a streak between two bands, hence the phosphorylation signal is 
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dispersed. In order to obtain a single band FmtA, pl of 9.58, can be seperated by an 
acidic-native PAGE (gel typically used for basic proteins with pl > 7.0). Based on Fig. 
2.3.8 it is suggested that FmtA may be a phosphorylation substrate for His-Stkl. PBP4, pl 
of 8.89, was used as a negative control. It should be noted that His-Stkl and GraR both 
have a pl < 7.0 and cannot enter the gel, this is especially noticeable for His-Stkl which 
remains in the stacking portion of the gel. 
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1Figure 2.3.8 His-Stkl phosphorylation of FmtA resolved by acidic-native PAGE 
The penicillin-binding protein FmtA (20 µM) was incubated either alone or with His-Stkl 
(10 µM) in the presence of [y-32P]- ATP (20 µM) in PB for 30 min at either 37°C or 
room temperature. GraR (10 µM) used as positive control and PBP4 (20 µM) used as 
negative control were subjected to same conditions. Note His-Stkl and GraR unable to 
enter gel due to pl. Reactions were resolved by 10% acidic-native PAGE. The gel was 
exposed to an autoradiography cassette, which was scanned using TYPHOON Trio+ (GE 
Healthcare) and subsequently stained with Coomassie blue. 
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2.3.5 Closer examination of GraR phosphorylation by His-Stkl 
Despite the identification of two potential substrates (FmtA and GraR), we 
decided to focus on the phosphorylation of GraR. The kinase assays involving His-Stkl 
and response regulators demonstrated specificity towards GraR only. BceR is a response 
regulator from Bacillus subtilis that shares 56% sequence identity to GraR (Fig. 2.3.9), 
did not undergo phosphorylation by His-Stkl (Fig.2.3.6). 
10 20 30 40 50 60 
BceR MFKLLLIEDDESLFHEIKDRLTGWSYDVYGIQDFSQVLQEFAAVNPDCVIIDVQLPKFDG-60 
GraR MQI-LLVEDDNTLFQELKKELEQWDFNVAGIEDFGKVMDTFESFNPEIVILDVQLPKYDG-59 
BceR FHWCRLIRSRSNVPILFLSSRDHPADMVMSMQLGADDFIQKPFHFDVLIAKIQAMFRRVH-121 
GraR FYWCRKMREVSNVPILFLSSRDNPMDQVMSMELGADDYMQKPFYTNVLIAKLQAIYRRVY-119 
BceR HYNTEPS-TIKTWCGAAVDAEQNLVSNDKGSVELTKNEMFILKQLIEQKNKIVSREELIR-182 
GraR EFTAEEKRTL-TWQDAVVDLSKDSIQKGDDTIFLSKTEMIILEILITKKNQIVSRDTIIT-179 
* * * BceR SLWNDERFVSDNTLTVNVNRLRKKLDALQLGAYIETKVGQGYIAKEEDKFYD-230 
GraRALWDDEAFVSDNTLTVNVSRLRKKLSEISMDSAIETKVGKGYMAHE-224 
Figure 2.3.9 Sequence alignment of GraR and BceR 
Highlighted in red and green are identical and similar amino acids, respectively. Putative 
phosphorylation sites ofGraR, Thr128, Thr130, and Tlhr49, are marked with asterisks. 
We further probed whether His-Stkl phosphorylates GraR in a time-dependent 
manner. As it can be seen in Fig. 2.3.10, the majority of phosphorylation, determined by 
the relative intensity of bands (analyzed by ImageJ 1.46q), takes place within the first 
30 min. Furthermore, to determine if phosphorylation is structure dependent, we boiled 
samples and repeated kinase assay. Based on Fig. 2.3.11, it is suggested that His-Stkl 
cannot phosphorylate a denatured GraR protein. 
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Figure 2.3.10 Time-dependent phosphorylation of GraR by His-Stkl 
Time-dependent phosphorylation of GraR (25 µM) by His-Stkl (20µM) in presence of ['Y-
.32P]-ATP (20 µM) and PB at various time intervals. Reactions were quenched with 5x 
SDS Gel-loading buffer and resolved with 15% SDS-PAGE. The gel was exposed to 
autoradiography cassette, scanned using TYPHOON Trio+ (GE Healthcare) and stained 
with Coomassie blue. Band intensity analyzed by ImageJ 1.46q and plotted against time. 
In an attempt to answer how much of the GraR protein undergoes 
phosphorylation we employed the Phos-tag PAGE method. Briefly, this gel separates 
phosphorylated species from non-phosphorylated on a PAGE gel that can be analyzed by 
Coomassie blue staining. Based on Fig. 2.3.12, no phosphorylated GraR was detected by 
Coomassie blue staining; however, low levels were detected by autoradiography. These 
results suggest that under these conditions GraR undergoes low-levels, < 5%, of 
phosphorylation by His-Stkl. As a control the same reactions were also separated by 
conventional SDS-PAGE. 
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Figure 2.3.11 Phosphorylation of thermo-denatured GraR by His-Stkl 
Denatured proteins were boiled for 10 min prior to reaction. 5 µM of native His-Stkl or 
denatured His-Stkl (His-Stkl 0 ) was incubated with native GraR or denatured GraR 
(GraR0 ) at 20 µM in presence of [y-32P]-ATP (20 µM) and PB for 30 min at room 
temperature. Reactions were resolved with 15% SDS-PAGE. The gel was exposed to 
autoradiography cassette, scanned using TYPHOON Trio+ (GE Healthcare) and stained 
with Coomassie blue. 
Albeit low levels of phosphorylation the results above indicate specificity 
towards GraR phosphorylation. Given that Stkl and Stpl are cotranscribed, and thus 
likely work as a pair, it was hypothesized that Stpl is responsible for removing the 
phosphate group from GraR. To test this we carried out a phosphorylation assay, where 
His-Stkl and GraR were first incubated with [y-32P]-ATP for 30 min at room temperature. 
Stpl was subsequently added and the reaction proceeded for 30 more min. Indeed, as seen 
in Fig. 2.3.13, Stpl was capable of dephosphorylation both His-Stkl and GraR. It should 
be noted that Stp 1 and GraR have similar molecular weights. 
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Figure 2.3.12 Quantifying GraR phosphorylation by Phos-tag PAGE 
A master mixture of His-Stkl (5 µM) and GraR (5 or 10 µM) was incubated with [y-32P]-
ATP (20 µM) and PB for 30 min at 37°C. Reactions were quenched and loaded 
simultaneously to both 12% SDS-PAGE and 12% Phos-tag PAGE (100 µM Mn2+-phos-
tag). The gels were exposed to autoradiography cassette, scanned using TYPHOON Trio+ 
(GE Healthcare) and stained with Coomassie blue. 
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Figure 2.3.13 Phosphatase activity of Stpl towards phosphorylated GraR 
His-Stkl (5 µM) was incubated with GraR (10 µM) and [y-32P]-ATP (20 µM) in PB for 
30 min at room temperature. Stp 1 (20 µM) was subsequently added to the mixture and the 
reaction proceeded for 30 min. Reactions were resolved with 15% SDS-PAGE. The gel 
was exposed to autoradiography cassette, scanned using TYPHOON Trio+ (GE 
Healthcare) and stained with Coomassie blue. 
2.3.6 Investigating the Stkl-mediated phosphorylation sites of GraR 
GraR is a transcription factor and belongs to the OmpR family of response 
regulators. This family of proteins is comprised of two clearly defined domains. We 
investigated which domain of GraR, the N- or the C-terminal, undergoes phosphorylation 
by His-Stkl. As observed in Fig. 2.3.14A the C-terminal domain of GraR, labeled GraRc, 
underwent phosphorylation and was suggested to harbor the phosphorylation site/s. The 
N-terminal, GraRN, did not undergo phosphorylation (Fig. 2.3.14B). 
To confirm phosphorylation and establish the number of phosphorylation sites 
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we opted for mass spectrometry analysis. His-Stkl and GraRc were incubated with and 
without cold ATP. Samples were separated by SDS-PAGE and the band of interest was 
cut out and trypsin-digested. These peptides were analyzed by liquid chromatography-
mass spectrometry (LC-MS/MS) at the Advanced Protein Technology Centre, The 
Hospital for Sick Children (Toronto, Canada). The results identified threonine 128, 130 
and 149 as the Stkl-mediated phosphorylation sites on GraRc (Fig. 2.3.15B). In the 
control reaction, His-Stkl incubated with GraRc in the absence of ATP, no 
phosphorylation modifications were observed (2.3.15A). 
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~ His-Stkl 
Radioactive Coomassie 
12.5% SDS-PAGE 
Figure 2.3.14 Phosphorylation of GraRc and GraRN terminals by His-Stkl 
His-Stkl (10 µM) and [y-32P]-ATP (20 µM) was incubated with A) 20 µM GraR-C 
terminal (GraRc) or B) 20 µM GraR-N terminal (GraRN) in PB for 30 min at room 
temperature. GraRc and GraRN were separated by 15% and 12.5% SDS-PAGE, 
respectively. Gels were exposed to autoradiography cassette and scanned using 
TYPHOON Trio+ (GE Healthcare). Only GarRN gel was further Coomassie stained. 
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It should be noted that full-length GraR was subjected to the same 
phosphorylation conditions as described above with cold ATP. The full length GraR was 
analyzed by liquid chromatography-mass spectrometry (LC-MS/MS) at the Centre for 
Research in Mass Spectrometry, York University (Toronto, Canada). This group 
confirmed the phosphorylation sites on the GraR C-terminal domain and ruled out any 
other phosphorylation sites, including the amino acids that span the GraR N-terminal 
domain. For ionization spectra refer to Appendix B. 
A) GraRc non-phosphorylated 
gill5923649 (100%), 26,039.8 Da 
two-component response regulator [Staphylococcus aureus subsp. aureus Mu50] 
13 unique peptides, 22 unique spectra, 455 total spectra, 95/224 amino acids (42% coverage) 
MQI LLVEDDN TLFQELKKEL EQWDFNVAGI 
ESFNPEIVIL DVQLPKYDGF YWCRKMREVS 
DNPMDQVMSM ELGADDYMQK PFYTNVLIAK 
FTAEEKRTLT WQDAVVDLSK DSIQKGDDTI 
.EILITKKNQI VSRDTllTAL 'WDDEAFVSDN 
KKLSEISMDS AIETKVGKGY MAHE 
B) GraRc phosphorylated 
gi I 15923649 (100%), 26,039.8 Da 
EDFGKVMDTF 
N V P I L F L S S R 
LQAIYRRVYE 
FLSKTlii~l IL 
TL TV N'V :SR LR 
two-component response regulator [Staphylococcus aureus subsp. aureus Mu50] 
13 unique peptides, 26 unique spectra, 601 total spectra, 95/224 amino acids (42% coverage) 
MQI LLVEDDN TLFQELKKEL 
E S F N P E I V I L D V Q L P K Y D G F 
DNPMDQVMSM ELGADDYMQK 
FTAEEKR~L~ WQDAVVDLSK 
EILITKKNQI VSRDTI ITAL 
KKLSEISMDS AIETKVGKGY 
128 130 
EQWDFNVAGI 
YWCRKMREVS 
PFYTNVLIAK 
D S IQ KG D 011 
WDD.EAFVSDN 
MAHE 
149 
E D F G K V M D T F 
N V P I L F L S S R 
L Q A I Y R R V Y E 
FLSKTEMI IL 
TLTVNVSRLR 
Figure 2.3.15 GraR phosphorylation sites determined by mass spectrometry 
His-Stkl (20 µM) was incubated with GarRc (40 µM) in PB at room temperature for 60 
min either A) without cold ATP or B) with cold ATP (500 µM). The highlighted portion 
(yellow) refers to amino acids within the unique peptides. Phosphorylation sites indicated 
in green with respective numbering. Data obtained from Scaffold program. The sequence 
coverage is 94% (95/101), not 42%, because it is the C-terminal only. For ionization 
spectra refer to Appendix B. 
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The identification of the putative phosphorylation sites on GraR allowed us to 
investigate whether mutating the threonine sites to alanine will have an effect on 
phosphorylation signal. Alanine residues do not undergo phosphorylation because they 
lack -OH group needed for substitution with phosphate group. Single GraR mutants 
where generated by site-directed mutagenesis and sequenced to ensure correct mutations. 
The results from these experiments suggest that all single mutants are capable of 
undergoing phosphorylation by His-Stkl (Fig. 2.3.16). These experiments are not 
quantitative but there is a slight decrease in phosphorylation signal on the GraR-T149A 
mutant. 
Given that mass spectrometry identified three phosphorylation sites and single 
mutant proteins were able to undergo phosphorylation, it was hypothesized that all three 
phosphorylation sites need to be mutated to fully abolish the phosphorylation signal. 
Following successful cloning of the GraR triple mutant, where all three tbireonine sites 
were mutated to alanines, various colonies were selected for expression. As can be seen in 
Appendix C there is high level of expression, however most, if not all, of the protein is 
aggregated in the pellet portion. In an attempt to solubilize the protein we carried out 
expression at lower concentrations of IPTG as well as lower temperature. However, the 
protein remained in the pellet portion and thus we were unable to purify the protein. 
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~His-Stkl 
~GraR 
Radioactive' 
Coomassie 
Figure 2.3.16 Phosphorylation of GraR single mutants by His-Stkl 
His-Stkl (5 µM) was incubated with GraR-WT (25 µM), GraR-T128A (25 µM), GraR-
T130A (10 µM) and GraR-T149A (25 µM) with 20 µM [y-32P]-ATP (10 Ci/mmol) in PB 
at room temperature for 30 min. Proteins were separated by 15% SDS-PAGE. Gels were 
exposed to autoradiography cassette, which were scanned using TYPHOON Trio+ (GE 
Healthcare), and stained by Coomassie blue. Note GraR-T130A was run on separate gel 
on different day. 
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2.4 Discussion 
Post-translational modification (PTM) in prokaryotes is an essential mechanism 
that allows modification of factors that ultimately govern the expression of other factors 
in order to maintain cellular equilibrium during stress. These stress responses, such as 
perturbations in the cell wall, are sensed and responded to by alterations in gene 
expression and protein activity. This is typically accomplished by two-component 
systems (TeS). The inherent properties of Tes to ensure bacterial survival prompted a lot 
of research in the field of signal transduction, in the hopes of exploiting these systems in 
order to decrease pathogenicity, resistance and virulence. 
Briefly, upon sensing external stimuli a histidine kinase undergoes 
autophosphorylation at a histidine residue and transfers the phosphoryl group to the 
aspartic acid residue of a cognate response regulator. This phosphorylation event controls 
the activity of the response regulator by inducing conformational changes in the active 
site, or modifying protein-protein interaction. The end result is usually an alteration of 
gene expression to revert physiological equilibrium back to normal following the stress. 
The majority of research in the field of prokaryotic signal transduction has 
focused on res, where the underlying theme is His/Asp phosphorylation. However, the 
discovery of Ser, Thr and Tyr phosphorylation in prokaryotes has propagated our 
understanding of the complex regulatory effects PTM can have on gene expression. A 
landmark study demonstrated the ability of Bacillus subtilis spores to exit dormancy by 
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sensmg favorable conditions in the surrounding milieu (Shah et al., 2008). It was 
demonstrated that a B. subtilis STK was capable of binding peptidoglycan fragments, in 
tum signaling cells via PTM to come out of dormancy. 
B. subtilis and S. aureus both contain one major STK, however, the latter does 
not form spores. Hence the function of the S. aureus STK, termed Stkl, is different then 
that of B. subtilis. Given the importance of Ser/Thr PTM and the lack of knowledge 
regarding Stk 1 function in S. aureus this work aims to address the molecular mechanisms 
of Stkl and cotranscribing Stpl in vitro, focusing specifically on phosphorylation of new 
substrates. 
Preliminary work by two independent groups paved the way for characterizing 
full length Stkl, and to a lesser extent, Stp 1, functions in vitro (Beltramini et al., 2009; 
Debarbouille et al., 2009). However, it was necessary to establish our own protocols for 
working with these proteins. The Stkl protein was expressed and purified as a His-tagged 
protein via Ni-NTA, whereas Stpl was expressed and purified natively based on the 
protein's pl. Contrary to the above-mentioned papers our data suggest that His-Stkl is 
capable of undergoing sufficient autophosphorylation with both magnesium and low-
levels of manganese as cofactors. Furthermore, it was found that higher levels of 
manganese decreased autophosphorylation activity of His-Stkl. This observation 
corroborates the study by Donat et al., 2009, where the authors demonstrated a simlar 
pattern of phosphoryaltion. 
Taken together, it is suggested that Stkl autophosphorylation in vivo relies on 
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magnesmm as a cofactor because ex~ess amount of manganese is toxic to the cell 
(Jakubovics and Jenkinson, 2001). One group has demonstrated that in vivo .survival of S. 
aureus depends on the manganese transport (Mnt) proteins (Horsburgh et al., 2002). It is 
interesting to propose that high-levels of manganese can upregulate the Mnt system, 
while simultaneously decreasing Stkl activity, thus ensuring cellular ion balance is 
achieved prior to committing resources to upregulating virulence genes. 
The versitility of phosphorylation depends on the reversibility of the reaction. In 
a prototypic TCS the histidine kinase is bifunctional and can catalyze both 
phosphorylation and dephosphorolation of its cognate response regulator (Laub and 
Goulian, 2007). Furthermore, the residues that undergo phosphorylation in TCSs, 
phosphohistidines and aspartyl-phosphates undergo rapid hydrolysis (Sickmann and 
Meyer, 2001; Stock et al., 1990). In contrast, phosphorylated Ser/Thr residues are less 
labile and have a much longer lifespan. Our data indicate that His-Stkl, following 
phosphorylation and removal of radioactive ATP, is stable for at least 30 min with no loss 
of signal. 
This prompted us to investigate the phosphatase activity of Stp 1 towards His-
Stk l. As expected, Stpl could completely dephosphorylate His-Stkl in vitro, resulting in 
complete removal of radioactive signal. The phosphatase activity of Stpl is necessary to 
quench the signaling cascade. Multiple studies have demonstrated that S. aureus strains 
with non-functional Stpl become more resistant to vancomycin (Cameron et al., 2012; 
Cheung and Duclos, 2012; Renzoni et al., 2011). It was previously suggested that one 
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factor important for vancomycin resistance was cell wall thickening (Cui et al., 2003), a 
phentoype observed in the S. aureus ~tpl strain (Beltramini et al., 2009). This phenotype 
likley arises from an "over-active" Stkl, where factors involved in cell wall synthesis, 
under the regulation of Stk 1, are constitutively active. It cannot be ruled out that Stp 1 is 
capable of dephosphorylating other targets besides Stkl. 
As previously mentioned, other groups have identified targets of Stk 1, such as 
the global transcription factors SarA and MgrA. However, a recent study in Streptococcus 
agalactiae identified a STK capable of phosphorylating a response regulator belonging to 
a TCS (Lin et al., 2009; Rajagopal et al., 2006). This observation was very intriguing 
because TCS pathways rarely cross talk at the level of phosphorylation with other 
systems. 
The hallmark of this study was the discovery that His-Stkl phosphorylates the 
response regulator GraR, which belongs to the GraSR TCS, in vitro. At the time of this 
writing, no peer-reviewed paper has established a connection between Stk 1 and a 
response regulator of a TCS in S. aureus. Furthermore no in vitro study has confirmed 
GraR phosphorylation by its cognate histidine kinase (as a result of the inability to obtain 
an active form of the protein). Thus His-Stkl-mediated phosphorylation, and not GraS-
mediated phosphorylation, of GraR will subsequently be referred to as GraR-P. 
It was determined that Stkl phosphorylated GraR in a time-dependent manner, 
where majority of phosphorylation occurred within 30 min. Furthermore, it was 
determined that Stpl was capable of removing phosphorylation signal from GraR-P. 
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Taken together our in vitro kinase assays suggest Stkl/Stpl are both involved m 
regulating GraR. 
In order to address whether His-Stkl phosphorylates GraR specifically we 
examined other S. aureus response regulators. It was determined that neither VraR nor 
WalR, under the conditions tested, could become phosphorylated in the presence of His-
Stkl. VraR belongs to the NarL family of response regulators (Belcheva and Golemi-
Kotra, 2008) and shares only 16% sequence similarity to GraR. WalR, on the other hand, 
shares 31 % sequence similarity with GraR and both proteins belong to the OmpR family 
of response regulators (Okajima et al., 2008). We further investigated whether His-Stkl 
could phosphorylate BceR, a response regulator from B. subtilis, which also belongs to 
the OmpR family and shares 56% sequence similarity to GraR. Interestingly, His-Stkl 
could not phosphorylate BceR. Also, when GraR was thermo-denatured it was unable to 
undergo phosphorylation by His-Stkl. Together these results suggest that His-Stkl 
specifically recognizes GraR at the molecular level, where unique structural folds 
determine recognition. 
We attempted to quantify GraR phosphorylation by separating phospho species 
from nonphospho using Phos-tag gel. Our data indicates His-Stkl phosphorylates <5% of 
GraR molecules under the conditions tested. The low level of phosphorylation could be 
due to suboptimal in vitro conditions, or another factor may be necessary to facilitate 
greater levels of phosphorylation. In order to speculate on the importance of 
phosphorylation levels in vivo, the total amount of GraR-P should be assessed by a more 
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accurate method such as mass spectrometry with an internal standard (Witze et al., 2007). 
Response regulators typically consist of two unique domains, the N- and C-
termini. The OmpR family of regulators are defined by their C-terminal amino acid 
sequence and three-dimensional structure (Itou and Tanaka, 2001; Martinez-Hackert and 
Stock, 1997). Given that GraR belongs to the OmpR family of response regulators and 
contains two unique domains, we were interested to determine which of these undergoes 
phosphorylation by His-Stkl. It was determined that phosphorylation was exclusive to the 
C-terminal domain, or DNA-binding domain, of GraR. It is beyond the scope of this work 
to dwell on the molecular effects phosphorylation could have on the C-terminal because 
no three dimensional structure of GraR exists. Needless to say these proteins tend to have 
flexible linkers, which allows for various dimer symmetries (Gao and Stock, 2009). 
Hence it remains to be determined whether phosphorylation enhances or represses DNA-
binding or alters protein-protein interaction. 
To confirm phosphorylation and determine the amino acids involved we sent 
GraR c and GraR c -P for LC-MS/MS analysis. Mass · spectrometry identified three 
phosphorylation sites on two different peptides: Thr128, Thr130 and Thr149. It should be 
noted some of these peptides were modified with both Thr128 and Thr130, suggesting · 
these two residues can be simultaneously phosphorylated. Interestingly, when comparing 
BceR and GraR amino acid sequences the putative phosphorylation sites are located in 
the region that contains the most variability between the two proteins (Fig. 2.3 .9). 
To confirm these findings we collaborated with Dr. Siu's research group (Centre 
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for Research in Mass Spectrometry, York University), which analyzed the full length 
GraR by mass spectrometry. Findings from the full length GraR corroborated our initial 
data regarding the phosphorylation sites. As well, no phosphory lated residues were 
identified in the N-terminal domain. 
To validate these results we opted for a mutagenesis approach, where single 
mutants of GraR, containing Thr to Ala mutations, were constructed. Despite the lack of a 
threonine residue, phosphorylation was attainable in all the GraR single mutants. There 
was a slight decrease in signal with the GarR-Thrl 49 mutant, but overall signal was not 
abolished. This result is contradictory to a recently published paper that described Stkl 
phosphorylation of the global regulator CcpA (Leiba et al., 2012). It was observed that 
CcpA undergoes phosphorylation at two threonine sites: Thr18 and Thr33. However, 
when only a single Thr was mutated to Ala the entire phosphorylation signal was 
abolished. This is quite perplexing, as mutating one Thr should leave the other Thr intact 
and capable of phosphorylation. 
We attempted to abolish phosphorylation by mutating all three Thr residues 
within GraR. We were able to clone the gene, however, when expressing the protein it 
became apparent that GraR-triple mutant was insoluble. It is very likely that 
simultaneously mutating three residues caused a deleterious affect on the three-
dimensional structure. Various methods were employed to solubilize the protein, such as 
decreased IPTG concentrations and lower temperatures (Sorensen and Mortensen, 2005). 
However, the GraR-triple mutant remained insoluble and we were unable to obtain 
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protein for further investigation. Even if we could resolubilize the protein from the pellet 
portion, it is very likely this protein is aberrant and lack of phosphorylation is more the 
result of improper folding then residue specificity. 
It should be noted that we observed phosphorylation of the penicillin-binding 
protein FmtA. It is unclear what the molecular mechanism or the significance of this 
phosphorylation is. 
Cumulatively we provide strong evidence that His-Stkl specifically 
phosphorylates GraR in vitro. More specifically, phosphorylation occurs on the GraR C-
terminal domain on three threonine residues: Thrl28, T130 and T149. Two separate mass 
spectrometry groups identified these residues. There was no evidence that other response 
regulators, regardless of family, were capable of undergoing phosphorylation by His-
Stk 1. The strongest data supporting our claim is that BceR, a homo log of GraR, was not 
phosphory lated by His-Stk 1. Through sequence alignments we were able to demonstrate 
the amino acid discrepancy in and around the putative phosphorylation sites between 
BceR and GraR. In conclusion, the findings herein aim at progressing our understanding 
of signal transduction mechanisms within the complex regulatory network of the S. 
aureus pathogen. 
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CHAPTER THREE 
ANALYSIS OF STKl-MEDIATED GRAR PHOSPHORYLATION 
IN VIVO 
3.1 Introduction 
Research on signal transduction in prokaryotes has primarily focused on two-
component systems (TCS) (Capra and Laub, 2012). The reason these systems were 
appealing to study was the result of faithful flow of information. Following sensing an 
external cue, the histidine kinase undergoes autophosphorylation and becomes active. The 
enzyme is then capable of phosphorylating its cognate response regulator, usually a 
DNA-binding protein, and a response is elicited. The important part of this flow of 
information is that the kinase and response regulator selectively recognize each other. In 
other words, there is very little cross talk with other TCS. In S. aureus there are 16 TCS 
(Kuroda et al., 2001 ), thus it's vital to tum on pathways only when required. 
Typically a single TCS is responsible for activating a very specific pathway, 
which makes in vivo investigation through knockouts a fairly straightforward task. For 
example, the S. aureus ~ vraSR mutant was found to be extremely sensitive towards many 
classes of antibiotics that act on the cell wall, such as fosfomycin, bacitracin, ~-lactams 
and teicoplanin (Kuroda et al., 2004). The authors concluded that the VraSR system had a 
profound effect on cell-wall peptidoglycan synthesis. Many instances exist where a TCS 
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is inactivated, a loss of function is observed, and in hindsight the loss of function is 
assigned to that particular TCS. Although slightly off-topic, this approach was so 
elegantly described by Yuri Lazebnik that anyone studying signaling pathways, apoptosis 
in the authors case, should give it a read (Lazebnik, 2002). 
Unfortunately this approach does not work so well with prokaryotic 
phosphorylation cascades involving Ser, Thr or Tyr residues, because kinases are 
promiscuous and multiple factors can be phosphorylated. In a recent review it was 
demonstrated that Mycobacterium tuberculosis has 11 kinases capable of Ser/Thr 
phosphorylation (Pereira et al., 2011), with a phosphoproteome containing over 300 
targets (Prisic et al., 2010). Furthermore these factors themselves have significant global 
impacts that yield pleiotropic phenotypes. 
Staphylococcus aureus strains contain one major STK (Stkl), however, in a subset 
of methicillin-resistant strains, such as MU50 and MW2, exists an atypical STK 
(Beltramini et al., 2009), termed Stk2 (SA0077 in N315). This second kinase does not 
traverse the membrane and thus contains no PAST A domains; it exists freely within the 
cytoplasm. Unpublished data suggests this second STK is active (Cheung and Duclos, 
2012) but it remains unclear as to what its physiological roles or targets are. To date it is 
accepted that Stkl carries out the majority of Ser/Thr phosphorylation in S. aureus. 
Despite the presence of only one identified STK in the majority of S. aureus 
strains, the removal of this gene causes a profound alteration in global gene expression. A 
transcriptome profile of an S. aureus ~tkl mutant demonstrated that of the 2,666 genes 
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evaluated expression of 72 ORFs were repressed and expression of 185 ORFs was 
increased (Donat et al., 2009). The authors concluded that the majority of these genes 
belong to nucleotide biosynthesis, cell wall metabolism, and central metabolic pathways. 
The important point here is that Stkl plays a global regulatory role in S. aureus; hence it 
is not much of a surprise that multiple targets are phosphorylated. And the 
phosphorylation of factors by Sktl could be an additional PTM to an already established 
layer of control. In Myxococcus xanthus it was found that a transcription factor can be 
under the control of a STK and a histidine kinase to control a single signaling event (Lux 
and Shi, 2005). 
The points raised above are intended to remind the reader of the challenges 
associated with assigning specific functions to STKs. Nonetheless, the aim of the 
following study is to investigate in vivo the relevance of our in vitro work, which has 
demonstrated that Stk 1 is capable of specifically phosphory lating GraR. Through 
complementation studies of an S. aureus !),.graR mutant, we aimed to understand the 
importance of the putative Stkl-mediated phosphorylation sites of GraR. 
83 
3.2 Materials and Methods 
3.2.1 Materials and chemicals 
Wizard® Genomic DNA Purification Kit for S. aureus genome extraction 
(Promega). QIAquick PCR Purification Kit was used to clean up DNA (Qiagen). Bacto TM 
Tryptic Soy Broth from BD (Becton, Dickson and Company) and Agar-Agar (granulated) 
from EMD (Millipore, USA). V ancomycin from Sigma Aldrich and chloramphenicol 
from EMD (Millipore, USA). 
3.2.2 Generation of complementation plasmid pMK4 
3.2.2.1 Construction of P native:graR and insertion into pSTBiue-1 
To construct the pMK4 complementation plasmid it was first necessary to 
separately amplify the DNA fragments of interest, ligate them together and insert into an 
intermediate plasmid pSTBlue-1. The promoter chosen was the native promoter (Pnative, 
175 hp) of the graXRS operon, which was amplified from S. aureus 63 90 genome with 
primer set Dir 5'- GCTAGGATCCCGCTAACATTGAAATGAAATTTTC and Rev 5'-
GCTACATATGCTAAAATACTCCTTTAAACTGTAAC. The fragments were 
separated with 1 % agarose gel and visualized by staining with ethidium bromide. The 
restriction cut sites BamHI (Dir primer) and Ndel (Rev primer) are underlined. 
The full-length graR gene (675 hp) was amplified from S. aureus 6390 genome 
with the primer set Dir 5'- GCTACATATGCAAATACTACTAGTAGAAGATGAC and 
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Rev 5'- GCTAGTCGACTTATTCATGAGCCATATATCCTT. The restriction cut sites 
Ndel (Dir primer) and Sall (Rev primer) are underlined. Following amplification the PCR 
products were cleaned up with PCR-clean up kit according to manufacturer 
recommendations, digested with Ndel and ligated at room temperature with T4 DNA 
ligase for 30 min. The resulting ligation product, designated P native:graR, was amplified 
with P native Dir and graR Rev primers to yield an 850 bp product. The P native:graR product 
was cloned within the multiple cloning site of pSTBlue-1 vector using the Perfectly Blunt 
Cloning kit. The resulting clone was used to transform NovaBlue cells, which were 
sequenced for the correct insert at The Centre for Applied Genomics, The Hospital for 
Sick Children (Toronto, Canada). 
3.2.2.2 Construction of pMK4-P native:graR 
The E. coli-S. aureus shuttle vector pMK4 (5.6 Kbp) was used for 
complementation studies where ectopic GraR expression was required. P native:graR, 850 
bp, was gel extracted from pSTBlue-1 following double digestion with BamHl/Sall. The 
vector pMK4 was digested with BamHl!Sall. The product and plasmid were cleaned up 
and ligated as described in 3.2.2.1. The resulting clone, pMK4-Pnative:graR, was used to 
transform NovaBlue cells, which were sequenced for the correct insert at The Centre for 
Applied Genomics, The Hospital for Sick Children (Toronto, Canada). 
3.2.2.3 Site-directed mutagenesis of Stkl-mediated phosphorylation sites in pMK4-
P native:graR 
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In order to study the importance of the putative Stkl-mediated phosphorylation 
sites of GraR, pMK4-Pnative:graR mutants were prepared. Double mutants harboring 
threonine to alanine substitutions at either Thr128 (encoded by ACA), Thr130 (encoded 
by ACT), Thr149 (encoded by ACG) and a triple mutant containing all three mutations 
were generated with the QuikChange™ Site-Directed Mutagenesis method (Stratagene). 
The three possible variations for double mutants (graR-Tl28A/Tl30A, graR-
Tl28A/Tl49A or graR-Tl30A/Tl49A) were generated via two rounds of amplification 
of the pMK4-Pnative:graR plasmid. Alanine substitutions are highlighted in bold within the 
PCR primers. The primers used were T128A 
CTGAAGAAAAACGTGCATTGACTTGGCAAG and Rev 5'-
CTTGCCAAGTCAATGCACGTTTTTCTTCAG, T130A Dir 5'- GAAAAA 
Dir 
CGT ACATTGGCTTGGCAAGATGC and Rev 5 ' - GCA TCTTGCCAAGCCAA 
5'-
TGTACGTTTTTC and T149A Dir 5'-AAAGGTGATCAGGCGATTTTC and Rev 5'-
GAAAATCGCCTGATCACCTTT. The triple mutant was constructed through three 
separate rounds of amplification with the above primers. Following each round of 
mutagenesis the constructs were digested with Dpnl and transformed into NovaBlue cells. 
Given the high success rate of site-directed mutagenesis the constructs were sequenced 
once all desired mutations were introduced (The Centre for Applied Genomics, The 
Hospital for Sick Children, Toronto). 
3.2.3 Introduction of pMK4-P native:graR into 6390 and ~graR mutant 
Following the successful generation of pMK4-Pnative:graR and the respective 
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mutants it was necessary to introduced these constructs into S. aureus. The pMK4-
Pnative:graR was electroporated with a time constant of 2.5 ms and voltage of 2 kV in a 1 
mm gap cuvette into restriction deficient S. aureus RN4220 strain which was plated on 
Tryptic Soy Broth (TSB)-agar containing chloramphenicol (40 µg/mL) and incubated for 
12-16 hrs at 3 7°C. Transformants were grown overnight in TSB supplemented with 
chloramphenicol ( 10 µg/mL) at 3 7°C and the plasmid was purified using the GeneJET 
Plasmid Mini prep kit (Thermo Scientific) with minor modifications. Briefly, lysostaphin 
( 10 µg) was incubated with 4 mL overnight culture in resuspension buffer at 3 7°C for 40 
min, followed by incubation at 80°C for 5 min and then chilled for 1 min on ice. Once the 
reaction warmed to room temperature the rest of the steps were carried out as per 
GeneJET Plasmid Miniprep kit (Thermo Scientific) instructions. The purified DNA was 
double-digested with BamHI and Sall to ensure the plasmid contained the insert of 
interest. 
The purified pMK4-Pnative:graR and respective mutants from S. aureus RN4220 
were further electroporated into S. aureus 6390 wild-type and 11graR (6390 background). 
3.2.4 Growth curve of 6390, 11graR and 11graR complemented (Thr-Ala mutation) 
mutant strains 
A growth curve was performed under optimal conditions in 250 mL glass flasks. 
To avoid the loss of plasmid strains containing pMK4 were always grown in 
Chloramphenicol ( 10 µg/mL ). Overnight seed cultures were grown in TSB at 3 7°C, 200 
rpm. The overnight culture was diluted into fresh 50 mL TSB medium to an OD600 of 
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0.05, this is considered time zero. Cultures were shaken at 37°C, 200 rpm and OD600 
readings were obtained by UV-Visible Spectrophotometer (Varian Cary 100 Bio) every 
60 min. 
3.2.5 MIC of 6390, !).graR and !).graR complemented (Thr-Ala mutation) strains 
Vancomycin · minimum inhibitory concentration (MIC) determinations were 
carried out in 96-well microtiter plate (300 µL culture volume). To avoid loss of plasmid 
strains containing pMK4 were grown in Chloramphenicol (10 µg/mL). Overnight seed 
cultures were grown in TSB at 37°C, 200 rpm and the OD600 measured prior to starting 
experiment. Bacterial cultures were grown until mid-log phase in 50 mL TSB, initially 
adjusted to OD6oo of 0.05, at 37°C for 180 min. Bacterial cultures were diluted 1000-fold 
with TSB and used to inoculate wells containing 2-fold increments of vancomycin 
concentrations, no Chloramphenicol was added at this step. Plates were incubated for 48 
hours at 37°C with no shaking and the OD600 was read on a Synergy H4 plate reader 
(BioTek). 
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3.3 Results 
3.3.1 Generation of complementation plasmid pMK4 
To investigate the relevance of GraR phosphorylation by Stkl we opted to use an 
S. aureus ~graR strain (graR knockout) and complement with plasmids containing wild 
type and mutant versions of the graR gene. The mutant plasmids have the putative Stkl-
mediated GraR phosphorylation sites, based on our in vitro data, mutated to alanines. In 
order to carry out the complementation experiment, it was first necessary to generate a 
plasmid to carry the gene of interest. The cloning strategy is illustrated in detail in Fig. 
3.3.1. 
In order for complementation to mimic physiological conditions we chose to use 
the native promoter (P native) of the graXRS operon, which has been described in detail 
(Falord et al., 2011 ). In between the promoter of interest and the graR gene is located 
another gene, graX, hence it was necessary to separately amplify the two fragments by 
PCR (Fig. 3.3.2A). Following amplification the Pnative, 175 hp, and graR, 675 hp, 
fragments were cleaned up with a PCR-clean up kit, to remove unwanted enzymes and 
buffer, and ligated with T4 DNA ligase to yield the product Pnative:graR, 850 bp (Fig. 
3.3.2B). Without the need for restriction digestion this construct was directly inserted into 
the linearized pSTBlue-1 vector using the Perfectly Blunt ® Cloning Kit (EMD 
Milli pore). 
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Figure 3.3.1 Cloning strategy for constructing pMK4-P native:graR 
BamHI 
A schematic depicting the cloning of the complementation plasmid pMK 4 containing the 
native promoter (P native) and the graR gene. The PCR products P native and graR were 
separately amplified from S. aureus 8325 genome by PCR, digested with Ndel and 
ligated together to yield the product Pnative:graR. The Pnative:graR product was directly 
inserted into pSTBlue-1 as blunt end. P native:graR was gel extracted from pSTBlue-1 
following double digestion with BamHI/Sall. pMK4 plasmid was also double-digested 
with BamHI/Sall and the two products were ligated to yield the final construct pMK4-
p native:graR. 
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Figure 3.3.2 PCR amplification and ligation of P native and graR 
A) The promoter of the graXRS operon, termed Pnative (175 bp), and the graR (675 bp) 
gene were separately PCR amplified from 8325 genome (similar to 6390). B) The 
fragments were digested with Ndel and ligated together to give the 850 bp product 
P native:graR. The graR fragment was run as control. All fragments separated by 1 % 
agarose and stained with ethidium bromide. 
The pSTBlue-1-Pnative:graR construct was transformed into NovaBlue cells and 
blue/white screening was performed to determine which colonies have the insert of 
interest. The white colonies were selected and double-digested to confirm insertion of 
Pnative:graR. As seen in Fig. 3.3.3, ten colonies were screened and two contained inserts. 
The empty pSTBlue-1 vector was run alongside as a control. The colonies with inserts 
were sent for sequencing. The sequencing result for the chosen insert used in subsequent 
cloning steps can be found in Appendix D. 
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Figure 3.3.3 Screening pSTBlue-1 for the P native:graR insert by double di:gestion 
Following Blue/White screen ten white colonies were chosen; the pSTmue-1 plasmid 
was isolated and double digested with BamHI and Sall. Colonies were considered 
positive for P native:graR upon the release of a fragment 850 bp in size. Reactions were 
separated by 1 % agarose gel and stained with ethidium bromide. 
Following the successful sequencing of the pSTBlue-1 construct it was necessary 
to double digest in order to obtain Pnative:graR for insertion into pMK4. The pMK4 
plasmid was also double digested with BamHI and Sall. The two fragments were ligated 
together, and the newly constructed plasmid was inserted into E. coli cells. As can be see 
in Fig. 3.3.4, twelve colonies were screened and all contained the insert. Two colonies 
were selected and the pMK4-Pnative:graR construct was sequenced. The sequencing result 
for these two colonies can be found in Appendix E. 
Following the successful generation the pMK4-Pnative:graR plasmid it was possible 
to proceed to mutating the putative Stkl-mediated threonine phosphorylation sites to 
alanines. Based on in vitro data it was suggested that mutating a single residue did not 
significantly abolish phosphorylation, thus we proceeded to making the three possible 
double mutants and a triple mutant. This was accomplished by using the Site-Directed 
Mutagenesis kit. All mutant constructs were sequenced. 
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Figure 3.3.4 Screening E. coli pMK4 for the P native:graR insert by doubie digestion 
The pMK4 plasmid was isolated and double digested with BamHI and Sall. Colonies 
were considered positive for P native:graR upon the release of a fragment 850 bp in size. 
Reactions were separated by 1 % agarose gel and stained with ethidium bromide. 
3.3.2 Electro po ration of pMK4-P native:graR into S. aureus strains 
Following correct sequencing of pMK4-Pnative:graR and respective mutants it was 
necessary to insert them into the S. aureus 11graR strain. The 11graR strain is a graR 
knockout strain that was generated from the wild type S. aureus strain 6390 by Dr. 
Ambrose Cheung's laboratory (Meehl et al., 2007). Given that pMK4-Pnative:graR was 
isolated from E. coli, it is necessary to insert the DNA into a restriction-deficient strain of 
S. aureus, referred to as RN4220. The DNA was electroporated into RN4220 and grown 
on chloramphenicol plates. It was noticed that higher chloramphenicol concentrations 
(>20 µg/mL) were required in order to reduce the background growth. Several colonies 
were selected and the insertion of Pnative:graR was confirmed by double digestion (Fig. 
3.3.5). 
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Figure 3.3.5 Screening S. aureus RN4220 pMK4 for the P native:graR insert by double 
digestion 
The pMK4 plasmid was isolated and double digested with BamHI and Sall. Colonies 
were considered positive for P native:graR upon the release of a fragment 850 bp in size. 
Reactions were separated by 1 % agarose gel and stained with ethidium bromide. 
The pMK4- Pnative:graR vector was isolated from RN4220 and inserted into !J..graR 
strain by electroporation and screened on TSB-agar plates containing 40µg/mL of 
chloramphenicol . For cloning purposes, as a control, 6390 was also electroporated with 
the pMK4-Pnative:graR vector. This construct was not used for subsequent experiments 
given 6390 already contains the graR gene. The S. aureus 6390 and !J..graR strains were 
able to grow in the presence of chloramphenicol upon successful electroporation of 
pMK4 plasmid. In order to prevent loss of plasmid, 10 µg/mL of chloramphenicol was 
added to subsequent experiments where strains harboring the plasmids were used. It 
should be noted that 40 µg/mL of chloramphenicol is required for selection when 
selecting colonies from plates. 
Although only the wild type pMK4-Pnative:graR was described in detail, the same 
process of passaging through RN4220 was carried out for mutant derivatives of pMK4-
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P native:graR harboring the threonine to alanine mutations. 
3.3.3 Growth curve of 6390 and '1.graR versus '1.graR complemented (Thr-Ala 
mutation) strains 
An interesting observation of the '1.graR strain was that it reached stationary phase 
much quicker then wild type 6390. Furthermore, the number of cells at stationary phase, 
based on OD600, was lower for '1.graR as compared· to wild type 6390 (Fig. 2.3 .6). Given 
this phenotype we tested whether '1.graR complemented with either pMK4-Pnative:graR or 
pMK4-Pnative:graR-mutants was capable ofreverting the phenotype back to normal. 
As can be observed in Fig. 3.3.6, all strains grew normally during early and mid 
exponential phase. Furthermore, the complemented strains all reverted the phenotype of 
the '1.graR mutant strain back to wild type. This is likely an indication that Stk I -mediated 
phosphorylation of GraR does not play a role in cell growth. Interestingly, the 
complemented '1.graR strains were capable of growing better then the wild type 6390. 
This is likely the result of multiple copies of the pMK4 plasmid within an individual S. 
aureus cell. 
3.3.4 Vancomycin MIC of 6390 versus '1.graR complemented (Thr-Ala mutation) 
strains 
Previous research by Meehl et al. has demonstrated that absence of graR 
sensitizes S. aureus strains towards vancomycin (Meehl et al., 2007). We tested this 
phenotype by assessing the MIC of the wild type 6390 strain against '1.graR and '1.graR 
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complemented strains. The results indicate that 
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Figure 3.3.6 Growth curve of 6390 and ~graR versus ~graR complemented (Thr-Ala 
mutation) strains 
Overnight seed cultures were diluted to an OD600 of 0.05 in TSB. The cultures were 
grown in flasks at 37°C, 200 rpm and readings were measured on a UV-Visible 
Spectrophotometer every 60 min. Chloramphenicol (10 µg/mL) added to cultures 
containing pMK 4 plasmid. 
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6390 has an MIC of 1 µg/mL towards vancomycin, whereas b.graR has an MIC of 0.5 
µg/mL (Fig. 3.3.7). The values are based on growth, an elevated OD6o0, in the particular 
well containing a given antibiotic concentration. If the OD6oo is above baseline, depicted 
by a more intense blue color (raw data can be found in Appendix F), then that particular 
antibiotic concentration is unable to inhibit bacterial growth. 
The lowest MIC value is determined by the well that contains no growth. All the 
b.graR-complemented strains were able to revert the MIC back to 1 µg/mL, which 
suggest that Stkl-mediated phosphorylation sites likely do not play a role in vancomycin 
resistance. 
Table 1 Vancomycin MICs of 6390, b.graR and b.graR complemented (Thr-Ala 
mutation) strains 
Strain Vancomycin MIC (111!fmL) 
6390 a 1 
b.graR a 0.5 
b.graR+pMK4:graR-WT a 1 
b.graR+pMK4:graR-Tl28A/Tl30A a 1 
b.graR+pMK4:graR-Tl28A/Tl49A b 1 
b.graR+pMK4:graR-Tl 30A/Tl 49A b 1 
b.graR+pMK4:graR-TRIPLE b 1 
a b Expenments were repeated at least three times or two times 
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3.4 Discussion 
All living organisms, regardless of their location on the phylogenetitc tree of life, 
must sense the constantly changing environment and respond accordingly. Multicellular 
organisms, in the classical sense, have specialized structures that relay information by 
converting it into a stimuli through nerve impulses. Prokaryotes on the other hand, such 
as S. aureus, depend upon two-component systems (TCS) for sensing and responding to 
environmental cues. Furthermore, it is becoming apparent that STKs, with their cognate 
STPs, also play an important role within this complex regulatory network. Together these 
systems respond and adapt to constantly changing environments. 
The identification of STKs in prokaryotes has facilitated the need to understand 
their physiological roles. Unfortunately this was not a straightforward task, as STKs can 
phosphorylate multiple targets, which lead to complex pleiotropic phenotypes. Given this 
complexity many studies in S. aureus probing for targets of Stkl have been carried out 
through in vitro kinase assays; such as the phosphorylation of MgrA (Truong-Bolduc et 
al., 2008), PurA (Donat et al., 2009) and Sar A (Didier et al., 2010). These are very 
important discoveries that lay the foundations for future studies that will address their 
significance in vivo. 
The discovery that Stkl phosphorylates GraR in vitro has prompted us to 
investigate our findings in vivo. The goal was to complement an S. aureus ts.graR mutant 
strain with both wild type and mutant version of the graR gene, ectopically expressed on 
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a plasmid, and assess phenotypic differences. The plasmid chosen for complementation 
studies was the pMK4 vector, a pC 194-fusion plasmid, which can replicate and yield 
chloramphenicol resistance in both E. coli and S. aureus (Sullivan et al., 1984). Majority 
of studies utilizing the pMK4 plasmid insert their gene of interest under the constitutively 
active P prot promoter (Leimeister-Wachter et al., 1992). Due to high levels of expression 
that is achieved from Pprot we sought to express the graR gene under its native promoter, 
in order to mimic physiological conditions. 
The native graR promoter regulates the entire graXRS operon (Falord et al., 
2011 ). In between the promoter and graR lies the graX gene, thus we amplified the two 
fragments separately and ligated them together to yield Pnative:graR. This fragments was 
inserted into the blunt end vector pSTBlue-1. Following sequencing the fragment was 
double digested from pSTBlue-1 and inserted directly into pMK4. The final product, 
pMK4-Pnative:graR was passaged through E. coli, then the restriction-deficient S. aureus 
RN4220 and finally l!lgraR. The flgraR strain has an S. aureus 6390 background, which is 
very similar to RN4220, but contains digestive enzymes to protect against foreign DNA. 
Thus whenever electroporating DNA into S. aureus strains it is necessary to use RN4220 
as an intermediate strain. 
In order to investigate the importance of Stkl-mediated phosphorylation sites we 
generated mutant pMK4-Pnative:graR plasmids where the Thr sites were mutated to Ala. 
The in vitro kinase assays demonstrated that mutating a single Thr to an Ala does not alter 
phosphorylation significantly, thus we chose to create either double mutations (two 
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threonines simultaneously mutated) or a triple mutant. All of these mutants were created 
through site-directed mutagenesis and ultimately inserted into the b.graR strain. 
Interestingly when working with S. aureus b.graR it was observed that this strain 
has growth defects based on its growth pattern. Following four hours of growth it was 
observed that b.graR plateaus much faster then all other strains, which is an indication 
that cells have reached stationary phase. In the wild type 6390 and all b.graR 
complemented strains stationary phase was reached following seven-eight hours of 
growth. All complemented strains, expressing either wild type GraR or mutated GraR, 
could restore growth to normal. Thus, it was concluded that in the absence of the putative 
Stkl-mediated phosphorylation sites on GraR does not significantly alter its function in 
the context of cellular growth. Based on the growth pattern it was also observed that all 
complemented strains contained more cells then the wild type strain during stationary 
phase, which is likely the result of multiple copies within a single cell since pMK4 
undergoes rolling circle mode of replication and thus yields multiple copies (Lindsay, 
2008). 
Previous research has suggested the absence of graR gene causes increased 
sensitivity towards vancomycin (Meehl et al., 2007), an antibiotic from the glycopeptide 
class (Moellering, 2006). To test whether the Stkl-mediated phosphorylation sites were 
important for activity of GraR we carried out MIC experiments towards vancomycin. It 
was observed that b.graR strain had an MIC of 0.5 µg/mL, whereas the wild type 6390 
strain had an MIC of 1 µg/mL. All the b.graR-complemented strains were able to revert 
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the phenotype back to 1 µg/mL, Stkl phosphorylation of GraR likely does not play a role 
in proper activity in the context of vancomycin resistance, given that ectopically 
expressed mutant version of GraR could restore !lgraR phenotype. Our in vitro data 
suggested that introducing three mutations at once causes the protein to misfold and 
aggregate. It was expected that when ectopically expressing the GraR-triple mutant in the 
!lgraR strain it should not be functional and phenotype should not be restored. However, 
given that the protein is expressed within its native cellular context it is likely chaperonin 
proteins and other factors aid in ensuring the protein is folded correctly. 
Unfortunately our complementation studies did not deduce the role of GraR 
phosphorylation by Stkl in vivo. A recent paper has suggested that although a given 
phosphorylation site does not yield immediate measurable effects on the target protein, it 
should not be ruled out as important (Cousin et al., 2013). Given that GraR plays an 
important role within the cell, relaxed substrate specificity could allow rapid adaptation to 
new environmental challenges. Alternatively, Stkl phosphorylation could be a "last-
resort" effort to counteract an unfavorable condition to which a TCS alone could not fully 
respond. Thus GraR could be part of a larger network of factors that Stk 1 phosphory lates 
as a global response. It remains to be determined what is the precise role of this 
phosphorylation event. Nonetheless, exploiting these systems by synergistically targeting 
multiple signaling pathways could render the S. aureus pathogen unable to respond and 
adapt. 
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CHAPTER FOUR 
GRAR REVISITED: IN VIVO INSIGHTS SUGGEST A MORE 
DIVERSE ROLE 
4.1 Introduction 
Prokaryotic signaling pathways have been extensively studied due to their roles in 
sensing and responding to unfavorable conditions. The S. aureus pathogen contains 16 
two-component systems (TCS) that collectively allow the organism to respond to a 
plethora of stimuli (Ito et al., 1999; Kuroda et al., 2001 ). Briefly, a TCS is composed of a 
histidine kinase, a cytoplasmic membrane protein that undergoes autophosphorylation 
following an external stimuli and a response regulator, usually a transcription factor, 
which receives this message in the form of phosphorylation to ultimately control gene 
expression (Chang and Stewart,.1998; Laub and Goulian, 2007; Stock et al., 2000). 
Some notable examples of TCSs include the VraSR system, where the VraS 
kinase senses perturbations in the cell wall and responds by phosphorylating VraR, which 
up regulates genes involved in the synthesis of new peptidoglycan (Kuroda et al., 2004; 
Yin et al., 2006). The HssSR system is involved in intracellular heme homeostasis, 
whereby phosphorylated transcription factor HssR binds within the hrtAB promoter and 
activates the expression of HrtAB, an efflux pump, in response to heme, hemin and 
hemoglobin (Stauff et al., 2007). In the context of bacterial adaptability these systems 
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play a vital role in responding to many different stimuli. It is beyond the scope of this 
work to understand all S. aureus TCS, hence subsequent discussion will focus only on the . 
GraSR system, which is the focus of this study. 
The GraSR, glycopeptide resistance associated, system is composed of a histidine 
kinase, GraS, and a response regulator, GraR. In the literature this system is also termed 
ApsSR, for antimicrobial peptide sensor, based on homology with Staphylococcus 
epidermidis (Li et al., 2007). Early studies suggested GraSR main role was to control the 
dlt and vraFG operons (Herbert et al., 2007; Meehl et al., 2007). The dlt operon encodes 
genes responsible for o-alanylation of teichoic acids (Peschel et al., 1999) and vraFG 
operon encodes a pair of proteins comprising an ABC transporter responsible for CAMP 
sensing and signaling (Falord et al., 2012). 
The genes controlled by GraSR help protect the S. aureus pathogen from human 
defense systems (Herbert et al., 2007). One important molecule that plays a role in 
suppressing bacterial infections is lysozyme, which acts as a cell wall lytic enzyme and a 
cationic antimicrobial peptide (CAMP). It is believed CAMPs act by disrupting bacterial 
membranes to allow free passage of ions, in turn disrupting homeostasis, which 
eventually leads to cell death (Sahl et al., 2005). The S. aureus pathogen has developed 
defense mechanisms to circumvent the actions of lysozyme. One of them is 0 -alanylation 
of teichoic acids, which adds an overall positive charge to the cell wall to repel the 
positively charged CAMPs. In fact, it has been shown that S. aureus strains lacking the dlt 
operon were highly susceptible to the actions of the host immune system (Collins et al., 
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2002). 
Although strong evidence exists that GraSR is primarily involv@d in the host 
immune adaptability, it is suggested the GraSR system plays a global regulatory role that 
is not limited to sensing and responding to CAMPs. A recent report has linked the GraSR 
system to the S. aureus stress response, cell wall and pathogenesis pathways (Falord et 
al., 2011 ). Based on transcriptome analysis and in silico genome scanning the authors 
identified new potential regulons of the GraSR system. Many TCSs are specific in the 
types of stimuli they can sense and respond to, however, the GraSR TCS is hypothesized 
to play a more global role than previously expected. The objective of this study was to 
further characterize the involvement of GraSR TCS in biological processes by studying 
an S. aureus '1.graR mutant. 
106 
4.2 Materials and Methods 
4.2.1 Materials and chemicals 
QIAquick PCR Purification Kit was used to clean up DNA (Qiagen). Bacto TM 
Tryptic Soy Broth from BD (Becton, Dickson and Company) and Agar-Agar (granulated) 
from EMD (Millipore, USA). Vancomycin from Sigma Aldrich and chloramphenicol 
from EMD (Millipore, USA). Congo Red (certified by the Biological Stain Commission, 
BioXtra) from Sigma. Osmium tetroxide 4% aqueous sol. and all other chemicals for 
transmission electron microscopy obtained from Electron Microscopy Sciences 
(Cedarlane). Deuterium oxide "100%" (D, 99.96%) from Cambridge Isotope 
Laboratories, Inc. 
4.2.2 Generation of pMK4-P native:graR-DSlN 
The pMK4-Pnative:graR plasmid was used as a template to mutate the Asp51 
(encoded by GAT) to Asn51 via the QuikChange™ Site-Directed Mutagenesis method 
(Stratagene ). Asparagine substitution is highlighted in bold within the PCR primers. The 
primers used were Dir 5'- CCTGAAATTGTTATATTGAATGTTCAATT 
ACCTAAATATG and Rev 5'- CATATTTAGGTAATTGAACATTCAATA 
TAACAATTTCAGG. Following amplification the product was digested with Dpnl and 
transformed into NovaBlue cells. The construct was sequenced at The Centre for Applied 
Genomics, The Hospital for Sick Children, Toronto. Following sequencing the correct 
construct was first electroporated into RN4220, followed by electroporation into flgraR as 
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section 3.2.3. 
4.2.3 Growth curve of6390 and ~graR complemented pMK4-Pnative:graR-D51N 
Growth curve were performed under optimal conditions in glass flasks. To avoid 
loss of plasmid, strains containing pMK4 were always grown in Chloramphenicol (10 
µg/mL ). !1dltA and Maro were used as controls. Overnight seed cultures were grown in 
TSB at 37°C, 200 rpm and the optical density at 600 nm (OD60o) measured prior to 
starting experiment in UV-Visible Spectrophotometer (Varian Cary 100 Bio). Bacterial 
cultures were grown in 50 mL TSB, initially adjusted to an OD6oo of 0.05. The initial 
OD600 was recorded and is considered time zero. Cultures were shaken at 37°C, 200 rpm 
and 0 D6oo readings were taken every 60 min. 
4.2.4 CFU of 6390 and ~graR at stationary phase 
Overnight seed cultures were grown in TSB at 3 7°C, 200 rpm and OD600 was 
measured prior to starting experiment in UV-Visible Spectrophotometer (Varian Cary 100 
Bio). Bacterial cultures were grown in 50 mL TSB, adjusted to a starting OD600 of 0.05, at 
3 7°C, 200 rpm for 480 min (corresponding to stationary phase). From each culture three 
separate biological replicates were removed and serially diluted (10-7, 10-8 and 10-9) in 
ddH20 and 10 µL of each dilution in quadruplicates was spotted onto TSA plates. The 
plates were dried for 15 min at room temperature and incubated at 3 7°C for 12-16 hrs. 
The total sample size for each strain is 12. 
108 
4.2.5 TEM of 6390 and ~graR 
Overnight seed cultures were grown in TSB at 3 7°C, 200 rpm. Cultures were 
diluted 100-fold and grown at 37°C, 200 rpm to OD6oo of 0.5. Cells (2 mL) were spun 
down and suspended in 500 µL of 3.5% glutaraldehyde and 0.1 M sodium cacodylate pH 
7.4 for 60 min. Mixtures were washed four times with 0.1 M sodium cacodylate pH 7.4 at 
room temperature with 15 min incubation in between each wash. Cells were post-fixed 
with 500 µL 1 % osmium tetroxide in 0.3 M sodium cacodylate pH 7.4 for 60 min at room 
temperature. Cells were spun down, suspended in 0.1 M sodium cacodylate pH 7.4 and 
incubated at 4 °C overnight. Subsequently cells were washed with 200 µL ethanol gradient 
of 30%, 50% and 80%, followed by 100% and incubated for 60 min. Fresh Spurr' s resin 
was prepared based on the manufacturers instructions and mixed with ethanol in 1: 1 ratio 
which was added to cell pellets. Mixture was left overnight at room temperature. The 
resin was removed and Fresh Spurr' s resin was prepared, without ethanol, and added to 
the cell pellets. Mixture was incubated at 70°C for 48 hrs, or until matrix resin 
polymerized. The resin was cut into sections, stained with uranyl acetate foJlowed by lead 
citrate and samples were examined using a Philips EM 210 transmission electron 
microscope at 80 kV with a SIA L3 camera (York University, Microscopy and Imaging 
Facility, Toronto). 
4.2.6 Congo Red susceptibility 
Overnight seed cultures were grown in TSB at 37°C, 200 rpm and OD600 was 
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measured prior to starting experiment in UV-Visible Spectrophotometer (Varian Cary 100 
Bio). To avoid loss of plasmid, strains containing pMK4 were always grown in 
Chloramphenicol (10 µg/mL ). Bacterial cultures were grown in 50 mL TSB, adjusted to a 
starting OD600 of 0.05, at 37°C, 200 rpm for 180 min (corresponding to mid-log phase). 
Cultures were serially diluted ( 10-2, 10-3, 10-4, 10-5, 10-6 and 10-7) in sterile ddH20 and 5 
µL of each dilution was spotted onto Congo Red agar (CRA) plates and TSA plates. The 
plates were dried for 15 min at room temperature and incubated at 3 7°C for 12-16 hrs in 
the dark. Furthermore, the plates were incubated for 8-12 hrs at room temperature in the 
dark. Pictures were taken with a Canon Powershot G-12 camera. The experiments were 
performed three times, independently. 
4.2. 7 WT A analysis of 6390, ~graR and complemented strains 
4.2. 7.1 PAGE analysis of NaOH-extracted WTA 
Overnight seed cultures, 10 mL, were grown in TSB at 37°C, 200 rpm. To avoid · 
loss of plasmid, strains containing pMK4 were grown in Chloramphenicol (10 µg/mL). 
Cells were pelleted by centrifugation (2,000 xg, 10 min) and suspended in 30 mL of 50 
mM 2-(N-morpholino)ethanesulfonic acid (MES), pH 6.5. Cells were pelleted as above, 
resuspended in 30 mL of 4% (wt/v) sodium dodecyl sulfate (SDS) in 50 mM MES, pH 
6.5 and placed in boiling water bath for 60 min. 
The samples were cooled, pelleted by centrifugation ( 10,000 xg, 10 min, room 
temperature) and resuspended in 1 mL of 4% SDS in 50 mM MES, pH 6.5. The cells 
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were transferred to 1.5 mL eppendorf tubes, pelleted by centrifugation ( 14,000 xg, 
10 min, room temeprature) and resuspended with 4% SDS in 50 mM MES, pH 6.5, 
followed by 2% NaCl in 50 mM MES, pH 6.5 and lastly with 50 mM MES, pH 6.5. 
The samples were treated with 1 mL containing 20 µg proteinase K in 20 mM 
Tris-HCl, pH 8.0, 0.5% SDS and incubated for 4 hrs at 50°C. Following incubation the 
samples were pelleted and resuspended once with 2% NaCl in 50 mM MES, pH 6.5 and 
three times with ddH20 to remove SDS. Finally, the pellets were resuspended in 1 mL 0.1 
M NaOH and shaken at room temperature for 16 hrs to hydrolyze ·WTA. 
The hydrolyzed WTA samples were separated on a 20% acrylamide gel using the 
Bio-Rad Mini-PROTEAN system with a 0.75 mM-thick glass plate. The stacking gel 
contained 3% acrylamide. Crude WTA, mixed with 50% glycerol containing traces of 
bromophenol blue, was loaded to fresh gels and run at 4 °C for 18 hrs in Tris-Tricine 
running buffer (0.1 MTris, 0.1 M Tricine, pH 8.2) with 16 mA as constant for two gels. 
WT A bands were visualized with the Alcian blue-silver stain method. Briefly, the gels 
were stained in 0.1 % (wt/v) Alcian blue overnight and subsequently silver stained as per 
kit instructions (Bio-Rad). 
4.2.7.2 NMR and PAGE ofTCA-extracted WTA 
Overnight seed cultures, 10 mL, were grown in TSB at 3 7°C, 200 rpm. To avoid 
loss of plasmid, strains containing pMK4 were grown in Chloramphenicol (lo· µg/mL). 
Cultures were diluted 200-fold in 1 L of TSB and grown at 3 7°C, 200 rpm to mid-
exponential phase. Cells were pelleted at 8,230 xg for 15 min, room temperature and 
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suspended in 10 mL of 2 M NaCL Cells were softened in water bath for 1 min, sonicated 
for 2 min with 35% amplitude and collected by centrifugation (14, 000 xg, 5 min, 4°C). 
They were further resuspended in PBS, vortexed, centrifuged. The pellets were 
resuspended in 20 mL of 4% SDS and incubated for 4 hr at 37°C with shaking. 
Cell walls were pelleted (14, OOOxg, 5 min, 25°C) and washed by resuspending 
three times with ddH20 by centrifugation. Covalently bound proteins and nucleic acids 
were removed by gentle stirring at 37°C overnight with 4 mL trypsin (0.2 mg/mL), 
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RNasel (0.1 mg/mL) and DNasel (0.1 mg/mL, 20µL) in 50 mM Tris-HCl, pH 7.0, 5 mM 
MgCh. Cell walls were recovered by centrifugation (14,000 xg, 5 min, 4°C,) and washed 
by resuspending and centrifuging with 1 M Tris-HCI, pH 7 .0 followed by 1 M Tris-HCI, 
1 M NaCl pH 7.0, then with 1 M Tris-HCl, pH 7.0 and lastly three times with ddH20. 
Following last wash, the pellets were resuspended in ice-cold 10% Trichloroacetic acid 
(TCA) in glass vial and incubated for 48 hrs at 4°C with constant stirring. 
The peptidoglycan was removed by centrifugation (5,300 xg, 45 min, 20°C) and 
the soluble portion ("'4 mL) was mixed with ice-cold 95% ethanol ("'20 mL) and solution 
was incubated for 5 days at 4 °C. The precipitated WT A is recovered by washing 
precipitate with 5 mL 95% ethanol two times (spin 5,000xg, 30 min, room temperature). 
Following last wash, resuspend in 1 mL of ddH20 and lyophilize ove~ight. At this stage 
pure WTA is observed as whitish powder, and for NMR analysis the WTA is suspended 
in D20 at final concentration of 5-10 mg/mL. For PAGE analysis, 200 ng of WTA was 
resolved as described above, with exception of running gel for 10 hrs. 
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4.3 Results 
4.3.1 Growth of 6390 and 11graR versus 11graR-D51N 
As observed in section 3.3.3, 11graR strains complemented with ectopically 
expressed GraR mutants harboring Thr to Ala mutations were capable of reverting the 
growth characteristics of !}.graR back to normal. This prompted us to investigate whether 
another post-translational modification was important for the growth phenotype. The 
graR gene is part of a two-component system termed GraSR. Although no in vitro work 
has confirmed GraS phosphorylation of GraR, recent in vivo work has suggested the 
aspartic acid at position 51 (D51) within the GraR N-terminal domain may be critical for 
activity (Falord et al., 2012). Through site-directed mutagenesis we generated a pMK4 
vector harboring a point mutation, Asp51 to Asn51, in the graR gene. 
When GraR-DSlN was ectopically expressed from pMK4-Pnative:garR-D51N in 
the !}.graR mutant, we did not observe a restoration of growth as compared to !}.graR 
complemented pMK4-Pnative:garR-WT (Fig.4.3.1). This indicates that the D51 residue, 
likely through GraS signaling, is involved in proper cell growth. 
It is well established that GraR controls the dlt operon, which is responsible for 0 -
alanylation of TA (adds positive charge). Furthermore the !1dltA mutant strain has been 
suggested to play a role in cell growth (Tabuchi et al., 2010), thus it was used as a control 
because it grows abnormally. To test whether the OD6oo corresponds to a lower amount of 
cells we carried out CFU to estimate the number of viable bacteria in the culture. 
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Figure 4.3.1 Growth curve of 6390 and 11graR versus ectopically expressed GraR-
WT and D51N 
Overnight seed cultures were diluted to an OD600 of 0.05 in TSB. The cultures were 
grown in flasks at 37°C, 200 rpm and readings were measured on a UV-Visible 
Spectrophotometer every 60 min. Chloramphenicol (10 µg/mL) added to cultures 
containing pMK 4 plasmid. 11dltA was used as a control to show aberrant cell growth. 
Cultures were harvested after 8 hrs of growth, which corresponds to stationary 
phase, serially diluted and spotted on TSA plates. As observed in Fig. 4.3.2, there are 
fewer viable 11graR and 11dltA cells as compared to the wild type 6390 strain. The number 
of cells in the 6390 wild type strain is three times more than 11graR mutant strain. 
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Figure 4.3.2 Viable cell count of 6390, !).graR and !).dftA after 8 hrs of growth 
The number of bacterial cells for strains 6390 and ~GraR was determined following 480 
min of growth, at 3 7°C and 200 RPM, by counting the number of colony forming units 
from a 1 OµL drop of a 108 dilution. For each strain three biological replicates were 
removed and spotted in quadruplicates, giving a sample size of n= 12 for each strain. 
4.3.2 Transmission electron microscopy 
The ~graR strain was further examined by transmission electron microscopy. The 
results demonstrate that deletion of the graR gene had a profound effect on cell 
morphology (Fig. 4.3.3). As can be observed the !).graR mutant strain contains a 
subpopulation of cells with aberrant septum positioning, where a second septa is parallel 
to an initiated or completed septum. This is very unusual given that septum positing in S. 
aureus is typically initiated at the end of daughter division and perpendicular to the fist 
plane of division (Turner et al., 2010). Examination of thousands of wild type 6390 cells 
did not reveal this phenotype; hence it is unique to the ~graR strain. Furthermore we 
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Figure 4.3.3 Transmission electron microscopy of 6390 and ~graR 
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Overnight cultures were diluted 1/1000 and grown at 37°C, 200 RPM to OD6oo of 1. Cells 
were harvested, fixed, immobilized in Spurr's resin and stained with heavy metal. No 
dual septa were observed in 6390 wild type, whereas only a subset of the population of 
11graR cells has dual septa (marked with arrow). Images are to scale with the 
corresponding magnification. 
complemented the tJ.graR strain with pMK4-Pnative:graR ectopically expressing GraR-WT 
and less mutant cells were observed, although aberrant septa positioning still occurred in 
some cells. 
4.3.3 Susceptibility towards Congo Red dye 
Scanning the literature it was observed that msrR mutation in S. aureus also gives 
rise to dual septa (Hubscher et al., 2009). Furthermore, the msrR mutation renders 
S. aureus cells more susceptible towards Congo Red, an anionic azo dye. Through PCR 
we were able to confirm that tJ.graR contains an intact copy of the msrR gene (Appendix 
G). Given the unique morphology between tJ.graR and tJ.msrR we decided to test tJ.graR 
susceptibility towards Congo Red. It should be noted that MIC could not be carried out in 
96-well microtiter plates due to the intense color of Congo Red. In order to assess 
bacterial turbidity the optical density is usually read at 600 nm, which corresponds to 
orange-red within the visible light spectrum. However, at various dilutions of Congo Red 
there will be variations in the light that passes through. Thus optical density will fluctuate 
not as a result of the bacterial density but more so the color of the dye. 
To overcome this we opted to use a variation of the Miles and Misra method 
(Hedges et al., 1978) on agar plates containing varying concentrations of Congo Red. 
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This experiment was recently carried out to assess susceptibility of WI A-deficient S. 
aureus strains towards Congo Red (Suzuki et al., 2012). Briefly, bacterial cultures are 
serially diluted and each dilution is spotted on a control plate, containing just nutrients 
and agar, and on test plates, containing nutrients, agar and varying concentrations of 
Congo Red. A strain is considered not susceptible if the number of colonies for each 
dilution is similar between the control and test plates. However, at much higher 
concentrations of cells (> 102) it is hard to distinguish between individual colonies, thus 
caution should be taken. 
Congo Red susceptibility tests revealed that !1graR was slightly sensitive towards 
Congo Red (Fig. 4.3.4) at concentrations >400 µg/mL. This is based on the observation 
that at 400 and 800 µg/mL Congo Red we expect 11graR to yield I 000, I 00 and I 0 cells 
corresponding to I 03, I 02, and I 01, respectively. Albeit a few colonies are observed, it is 
nowhere near the expected amount, thus these colonies likely form chance mutations 
resulting from stress. The wild type 6390 strain was capable of growing on all plates and 
was not considered sensitive towards Congo Red. As a control the S. aureus MarO strain 
was included, a strain lacking WT A and as a result becomes sensitized towards Congo 
Red (Suzuki et al., 2012). This strain has an MIC of 4 µg/mL and could not grow on the 
plates containing 200, 400 or 800 µg/mL Congo Red. Furthermore, to showcase the 
sensitivity of this experiment, Maro was grown on plates containing I 0, 50 and I 00 
µg/mL Congo Red, and as can be seen in Appendix H on the 10 µg/mL Congo Red plate 
growth could only be observed when 106 cells are present. 
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Figure 4.3.4 S. aureus 6390 wild-type, ~graR, RN4220~dltA and RN4220Mar0 
susceptibility towards Congo Red 
Cells in log phase were cultured, serially diluted, and 5 µL of each dilution was spotted 
onto either TSA or TSA plates containing 200, 400 or 800 µg/mL of Congo Red dye 
(termed CRA). Plates were incubated at 37°C in the dark for 12 hrs, and further another 8 
hrs at room temperature. Congo Red is light sensitive. At higher concentration of Congo 
Red colonies tum black. Furthermore, colonies may also remain red and thus hard to 
observe against the red plate background. Expected colony number indicated at top. 
119 
The dltA gene, within the dlt operon, is responsible for adding a net postivie 
charge to T As. Given that GraR controls dlt operon we examined whether ~graR 
sensitivity is a result of charge variations. As observed in Fig. 4.3.4 the ~dltA mutant 
strain (d/tA-difficeint) was not sensitive towards Congo Red, due to the ability to grow on 
all tested concentrations. Hence it is suggested that ~graR sensitivity towards Congo Red 
is not the result of charge differences. 
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pMK4:graR-D51N 
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Figure 4.3.5 S. aureus ~graR complemented with GraR-WT and GraR-D51N 
susceptibility towards Congo red 
Cells in log phase were cultured, serially diluted, and 5 µL of each dilution was spotted 
onto either TSA or TSA plates containing 200, 400 or 800 µg/mL of Congo Red dye. 
Plates were incubated at 3 7°C in the dark for 12 hrs, and further another 8 hrs at room 
temperature. Congo Red is light sensitive. At higher concentration of Congo Red colonies 
tum black. Furthermore, colonies may also remain red and thus hard to observe against 
the red plate background. Expected colony number indicated at top. 
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We attempted to complement the 1!!,.graR strain with the pMK4-Pnative:graR-WT 
plasmid, however surprisingly, as can be obserevd in Fig. 4.3.5 the complemented strain 
remained sensitive twoards Congo Red. Likewise, so did the pMK4-Pnative:graR-D51N 
complemented 1!!,.graR strain. It is possible the plasmid was lost during cell growth and 
unable to fully complement as the plates did not contain chloramphenicol to maintain the 
plasmid. 
4.3.4 PAGE analysis ofWTA 
The unique phenotypes observed for l!!,.graR suggest its involvement in cell growth 
and alterations in WT A composition and/or modification. WT A was extracted from S. 
aureus strains by both NaOH method and TCA method. Briefly, the NaOH is a relatively 
quick procedure, where cell wall is removed and WTA is hydrolyzed by NaOH. However 
a limitation of the NaOH method is that the 0 -alanine ester group is labile at alkaline pH. 
The TCA method is quite laborious and time-consuming, but yields very pure WT A with 
the 0 -alany 1 group attached. 
NaOH-extracted WTA was analyzed by 20% PAGE and as observed in Fig.4.3.6 
the 1!!,.graR WTA migrated faster as compared to the wild type 6390 WTA. The ability of 
WT A to migrate faster has previously been attributed to WT A lacking sugars (Meredith 
et al., 2008). The S. aureus K6 strain, which completely lacks sugar modifications on 
WT A, was used as a control. Although 1!!,.graR WT A did not migrate as quickly as K6 
WT A, it still migrated faster than wild strain 6390 WT A. It is possible that 1!!,.graR 
produces WTA void of sugar modifications; however, it is also possible that faster 
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migration could be the result of !lgraR WT A polymer length. 
20%PAGE 
Figure 4.3.6 PAGE separation ofNaOH-extracted WTA from 6390, !lgraR and K6 
WTA from 6390, !lgraR and K6 was extracted at log phase following growth at 37°C, 
200 rpm in TSB via the NaOH method. Crude WT A separated by 20% PAGE and run for 
18 hrs and bands were visualized with the Alcian blue-silver stain method. S. aureus K6 
WT A, completely lacks sugars, used as control. 
When GraR-WT was ectopically expressed from pMK4-Pnative:garR-WT in the 
!lgraR mutant, we observed a restoration of WT A migration identical to that of wild type 
6390 (Fig.4.3.7). It should be noted that for this experiment WTA was extracted by the 
TCA method, and the PAGE gel was separated for 10 hrs, as opposed to 18 hrs. Had the 
gel been run longer the migration difference would have been more apparent. 
Nonetheless, ectopically expressed GraR complemented the !lgraR strain. 
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Interestingly, the GraR-D51N, ectopically expressed from pMK4-Pnative:garR-
D51N in b.graR, could not restore WTA migration back to normal. This is indicative that 
the D51 residue is required for activation of the GraR protein, and given GraS is 
responsible for phosphorylation of GraR at that residue, it is suggested both proteins play 
a role in WT A synthesis and/or modification. 
20%PAGE 
Figure 4.3. 7 PAGE separation of TCA-extracted WTA from 6390, b.graR and b.graR 
complemented strains , 
WTA from 6390, b.graR and b.graR mutant complemented with GraR-WT and D51N was 
extracted at log phase following growth at 3 7°C, 200 rpm in TSB via the TCA method. 
WT A (2 µg) was separated by 20% PAGE, run for 10 hrs and bands were visualized with 
the Alcian blue-silver stain method. 
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4.3.5 NMR analysis of WT A 
NMR analysis of TCA-extracted WTA was carried out to further investigate the 
differences between !1graR mutant and 6390 wild type WT As. This was done in 
collaboration with Dr. Hunter (The NMR Facility, York University). Both 1H-NMR and 
2D-HSQC were acquired, however only the 1H-NMR will be discussed in detail. For the 
2D-HSQC data refer to Appendix I and J. 
Although not fully quantitative, the peak size of the o-alanine methyl group, 
8=1.542, can be compared to the methyl group of N-acetylglucosamine (GlcNAc), at 
8=2.000. Upon closer inspection of the 1H-NMR spectrum it was observed that 11graR 
WTA (Fig. 4.3.8B) contains less 0~alanine esterification as compared to 6390 wild type 
WTA (Fig. 4.3.8A). This is expected given the regulatory role of GraR on the dlt operon. 
However, the 0 -alanine peak in 11graR does not fully diminish, suggesting either a basal 
level of dlt expression or compensation by another regulator. 
Interestingly, when wild type GraR is ectopically expressed from pMK4-graR-
WT in the 11graR mutant the size of the methy 1 peak of 0 -alanine returns to wild type 
levels (Fig. 4.3.9A). However, when GraR-D51N is ectopically expressed from pMK4-
graR-D5 lN in the 11graR mutant the methyl peak remains similar to that of 11graR (Fig. 
4.3.9B). This observation suggests the D51 residue is important for GraR function in 
decorating WT A with 0 -alanine. 
The GlcNAc group can be linked to the WTA poly-RboP backbone by an a-, 
8=5.020, or ~-, 8=4.643, glycosidic bond. The 1H-NMR spectrum revealed that 6390 and 
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11graR WTA contain a and ~-GlcNAc (Fig 4.3.8), albeit slightly less ~-GlcNAc was 
observed in the 11graR mutant WT A. 
Lastly, an unassigned peak, 8=4.9, is present in both 6390 and 11graR WTA, 
however, this peak is very pronounced in the 11graR WTA (Fig. 4.3.8A and B). Of 
particular interest is that this peak is also present in the 11graR strain ectopically 
expressing GraR-D51N, but not GraR-WT (Fig. 4.3.9A and B). It is unclear what this 
peak is and further investigation is necessary. However, it is suggested that enlargement 
of this peak is the result of the absence of GraR or the presence of a mutant GraR 
harboring a D51N mutation, which renders it unable to undergo phosphorylation by GraS. 
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Figure 4.3.8 1H-NMR spectral data ofTCA-extracted WT As from 6390 and figraR 
NMR spectral data of A) 6390 and B) !J.graR mutant. Abbreviations are as follows: H is 
hydrogen, Rho is ribitol, GlcNAc is N-acetylglucosamine and 0 -Ala is alanine. 
Uncharacterized peak at -4. 9. 
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Figure 4.3.9 1H-NMR spectral data of TCA-extracted WTAs from !).graR mutant 
complemented with GraR-WT and D51N 
NMR spectral data of A) !).graR + pMK4:graR-WT and B) !).graR + pMK41:graR-D51N. 
Abbreviations are as follows: H is hydrogen, Rbo is ribitol, GlcNAc is N-
acetylglucosamine and o-Ala is alanine. Uncharacterized peak at ..... 4.9. It should be noted 
H~ was not detected because the adjacent H20 peak masked the signal. 
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4.4 Discussion 
The identification of the first prokaryotic TCS in 1986 had a profound effect on the 
field of signal transduction (Nixon et al., 1986). At the time scientists were vigorously 
investigating phosphorylation events in eukaryotic system, and it was quickly becoming 
apparent that post-translational modification of proteins has a profound effect on gene 
expression and ultimately cellular physiology. Furthermore researcher realized that 
phosphorylation is not limited to eukaryotic systems and is widespread in prokaryotes as 
well (Cozzone, 1988). In prokaryotes such as S. aureus signal transduction typically 
involves TCSs, which are comprised of a sensor histidine kinase and a response regulator 
capable of binding DNA (Capra and Laub, 2012). 
In S. aureus the GraSR TCS has been identified to be important in conferring 
resistance to antimicrobial peptides (Herbert et al., 2007) and as a consequence the 
majority of studies have focused on this particular response. It was widely accepted that 
GraSR controls the dlt, mprF and vraFG operons, whereby the genes upregulated are 
involved in either sensing or conferring resistance to CAMPs. However, a recent study 
has suggested that GraSR may in fact regulate many other genes involved in virulence, 
stress response and cell wall signal transduction (Falord et al., 2011). As a result of this 
study we hypothesized that certain phenotypes were previously overlooked. Hence the 
aim of this study was to investigate these newly identified characteristics of GraSR in 
vivo. 
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To investigate the GraSR system in vivo, we chose to work with an S. aureus 11graR 
mutant. Although this mutant has an intact graS gene, the lack of the transcription factor 
graR renders this system inactive due to the inability to regulate gene expression. As was 
observed in section 3.3.3, the 11graR mutant had growth defects, where stationary phase 
was reached quicker than 6390 wild type. Furthermore, all pMK4-Pnative:graR constructs 
tested in section 3.3.3 could restore growth to wild type levels. This observation promoted 
us to investigate the GraS-mediated phosphorylation site, Asp5 l, within GraR. 
Although no in vitro studies confirmed phosphotransfer, through in vivo studies the 
site on GraR that undergoes phosphorylation by GraS has been suggested to play an 
important role (Falord et al., 2012). Interestingly, the tigraR strain complemented with 
ectopically expressed mutant GraR-D5 lN could not restore cellular growth to wild type 
levels, whereas the ectopically expressed GraR-WT could. This observation is strong 
evidence that the GraSR system is involved in cellular growth and the D51 site is 
important for proper function. It should be noted that growth defects were based on 
optical densities and it was determined that a lower optical density does indeed correlate 
with a lower viable cell count. 
The dlt operon consists of four genes, but it is sufficient to inactive dltA gene, the 
ligase, in order to sufficiently decrease o-alanylation of teichoic acids. It is suggested that 
11graR growth defect may be the result of decreased alanylation of teichoic acids. The S. 
aureus !1dltA mutant was used as a control and had similar phenotype as 11graR. This 
observation corroborates the study by Tabuchi et al., 2010, which also observed similar 
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defects in the ~dltA strain. Taken together these results indicate that GraSR system is 
involved in proper cell growth, but further research would be required to determine if 
~graR defects are due to lowered dltA expression. Lowered o-alany lation of WT A has 
been shown to increase magnesium ion binding to cell wall (Lambert et al., 1975). 
Although lucrative to speculate high concentrations of magnesium could explain ~graR 
defects it is unlikely as high magnesium concentrations have been shown to have a 
positive effect on cellular growth (Bhat et al., 1994 ). 
The morphology of ~graR mutant was examined by thin-section transmission 
electron microscopy. Arguably the most important discovery of this study was that a 
subpopulation of !3.graR mutant cells contained aberrantly positioned septa. It is 
extremely uncommon for a cell that has initiated division to begin a second division plane 
parallel to an already initiated septum. Examination of thousands of S. aureus 6390 wild 
type cells did not reveal even one cell with this phenotype. 
In nearly all prokaryotes, cell division is initiated with the polymerization of the 
tubulin-like protein FtsZ that forms the Z-ring at midcell (Adams and Errington, 2009). 
The Z-ring serves as a scaffold for the recruitment of cellular components required for 
cell division, collectively this is called the divisome, which is responsible for synthesis of 
new cell wall (Errington et al., 2003). This process is tightly regulated and can only occur 
after chromosome segregation in order to avoid bisection of the genomic content by the 
division apparatus. It has been demonstrated that the S. aureus nucleoid occlusion 
effector, Noc, determines the placement of the FtsZ ring (Veiga et al., 2011 ). It is unclear 
130 
what regions of DNA the Noc protein recognizes and binds, but it is suggested correct 
septum positioning heavily depends on this protein (Wu and Errington, 2012). 
It is not apparently obvious what causes the dual septa formation in the t,.graR 
strain, as the noc gene was not identified to be under the control of the GraSR system 
(Cui et al., 2005; Falord et al., 2011). Furthermore it is not even clear if noc deficiency 
gives rise to such a phenotype, but it is a likely candidate. The dual septum phenotype has 
been previously identified in an S. aureus ~msrR mutant, but the authors did not give a 
plausible explanation for this phenomenon (Hubscher et al., 2009). The msrR protein 
belongs to the LytR-CpsA-Psr (LCP) family of membrane proteins that have been 
implicated to play an important role in cell separation, autolysis, cell surface modification 
and virulence (Hubscher et al., 2008; Over et al., 2011). It is interesting that the msrR 
gene is one gene away from mprF, a gene that has been well established to be regulated 
by the GraSR system (Li et al., 2007). No GraR consensus binding sequence was found 
upstream of msrR (Falord et al., 2011), thus it remains t~ be determined whether GraSR 
can directly or indirectly regulate expression of this gene. It is also unclear if dual septa 
formation in ~graR and ~msr R is related or deficiencies in two unrelated mechanisms 
just happen to give rise to the same phenotype. 
The similarities between ~graR and ~msr R strains prompted us to investigate other 
phenotypes. It was shown that an S. aureus t,.msrR mutant strain is more sensitive 
towards Congo Red dye (Hubscher et al., 2009). Our data indicate that t,.graR is also 
sensitive towards Congo Red at concentrations > 400 µg/mL. Unexpectedly the t,.graR 
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strain complemented with ectopically expressed GraR-WT could not restore resistance to 
wild type levels. It is proposed that complemented cells may have lost the plasmid, as the 
plates contained no antibiotic for plasmid selection. We also cannot rule out the 
possibility that another mutation besides 11graR exists within the S. aureus strain causing 
sensitivity towards Congo Red. This was the only instance in which the complemented 
strain was unable to restore a phenotype to wild type levels. 
Congo Red mode of action towards S. aureus is unknown, but it was recently 
shown that cells lacking WT A, due to mutations in tarO gene, become extremely 
sensitive towards the dye (Suzuki et al., 2012). The authors concluded that WTA confers 
protection against Congo Red and other dyes of related structure. We sought to 
investigate whether decoration of WT A backbone is responsible for sensitizing cells 
towards Congo Red. Given that GraSR controls the dlt operon, and dltA is involved in 0 -
alanylation of teichoic acids (increased net positive surface charge), we hypothesized that 
charge could play a role in sensitizing 11graR towards Congo Red. However, it was 
observed that S. aureus 11dltA is comparable to wild type and is not sensitive towards 
Congo Red. Our data also corroborates that S. aureus MarO mutant strain is very 
sensitive towards Congo Red. Taken together, we conclude that lack of dltA, which 
produces an overall negative charge on teichoic acid, does not sensitize S. aureus towards 
Congo Red. Thus 11graR sensitivity towards Congo Red is not due to altered surface 
charge as a result of lowered dltA expression. 
In addition to o-alany lation, wall teichoic acids are also decorated with a- and ~-
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GlcNAc (Swoboda et al., 2010; Xia et al., 2010a). We hypothesized that sensitivity 
toward Congo Red could in part be due to sugar modifications within b.graR WT As. Our 
studies indicate that there are significant differences between b.graR and wild type 
WTAs. PAGE analysis reveled that b.graR WTA migrates faster than wild type WTA. It 
is proposed that b.graR WTA contains less sugar modifications and thus migrates faster. 
This has previously been observed in an S. aureus mutant, K6, which completely lacks 
both a- and~- GlcNAc (Xia et al., 2010b). One could argue that b.graR migrates faster as 
a result of charge differences, but we have isolated WTA by NaOH and TCA method and 
observed similar migration patterns. In the NaOH method the o-alanine esters get 
hydrolyzed whereas in the TCA method they remain attached. Another possibility that 
cannot be excluded is that b.graR WT A backbone is comprised of fewer polymer units, 
resulting in shorter WT A. The lack of higher molecular weight polymers in b.graR WT A 
would give the impression of faster migration. 
Closer examination of the b.graSR transcriptome revealed that tarM, the gene that 
attaches a-GlcNAc units to WTA, is down regulated (Falord et al., 2011). Furthermore 
the authors identified tar M operon as one of 26 potential GraSR regulon members based 
on a highly conserved ten base pair palindromic sequence. Unfortunately the authors 
could not confirm DNA-binding in vitro because they were unable to get an active form 
of GraR. Although we did not test GraR binding to the tar M operon, based on NMR 
analysis of WT A it is suggested that indeed b.graR contains alterations in WT A content. 
It is yet to be determined if these differences are indeed alterations in a- and/or ~-
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GlcNAc content within WTA. 
In conclusion, the aim of this study was to uncover novel phenotypes of the GraSR 
system through in vivo investigations of an S. aureus fl.graR mutant strain. It is suggested 
that previous studies, primarily focusing on CAMP resistance, have overlooked other 
importance regulatory roles of the GraSR system. It was shown that 424 genes were 
differentially expressed in the fl.graSR mutant compared to wild type (Falord et al., 2011 ). 
Our studies, together with Falord et al., suggest a more global role for GraSR. In this 
study we have discovered defects in cellular growth and division, sensitivity towards 
Congo Red and alterations in WT A. This global regulation is substantiated by the large 
regulon size of the GraSR system. Thoroughly understanding TCSs such as GraSR allows 
us to develop targeted, small-molecule therapeutics to exploit these systems. 
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CHAPTER FIVE 
SUMMARY AND FUTURE DIRECTION 
5.1 Summary 
The goal of this study, primarily chapters 2 and 3, was to expand our knowledge 
on S. aureus Ser/Thr kinase, Stkl, and phosphatase, Stpl. Since their discovery a number 
of research groups have aimed to address the importance of these proteins, both through 
in vitro and in vivo studies. Several substrates were identified as phosphorylation targets 
of Stkl in vitro. It has also been observed that Stkl/Stpl knockout strains give rise to 
pleiotropic phenotypes. However, these phenotypes cannot be explained solely through 
the regulation of the identified substrates. This observation led us to postulate that other 
substrates exist. 
We have successfully cloned, expressed and purified His-Stkl/Stpl and through 
kinase assays demonstrated their enzymatic activity. Through in vitro kinase assays it was 
shown that His-Stkl undergoes phosphorylation in a time dependent manner. Following 
phosphorylation His-Stkl can remain phosphorylated for a prolonged period of time, or 
until Stpl is added which can completely dephosphorylates His-Stkl. Analysis of !J,.graR 
and thltkl transcriptomes revealed that a number of genes are similarly regulated, which 
prompted us to investigate whether His-Stkl can phosphorylate the response regulator 
GraR. It was shown that His-Stkl could specifically phosphorylate GraR in a time-
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dependent manner and Stpl could dephosphorylate GraR. 
To increase our confidence that His-Stkl phosphorylation of GraR was specific 
we examined other transcription factors, either from same or different family as GraR. 
Our data suggest that BceR, a homo log of GraR which shares 56% sequence similarity, is 
unable to undergo phosphorylation by His-Stkl. Furthermore VraR and WalR, which 
share much less sequence similarity, also do not undergo phosphorylation by His-Stkl. 
The GraR protein is composed of two unique domains, and it was demonstrated that 
phosphorylation was exclusive to the C-terminal domain. The N-terminal domain did not 
undergo phosphorylation by His-Stkl. Mass spectrometry analysis of His-Stkl-
phosphorylated C-terminal domain revealed that phosphorylation occurs on three 
threonine residues: Thr128, 130 and 149. We further collaborated with Dr. Siu's research 
group (Centre for Research in Mass Spectrometry, York University) and analyzed full 
length GraR. This group corroborated the putative phosphorylation sites and excluded any 
phosphorylation within the N-terminal domain. 
Following identification of the phosphorylated sites, we created GraR mutant 
proteins. Through site-directed mutagenesis we generated three single mutants, where a 
threonine 128, 130 or 149 was mutated to an alanine. Following expression and 
purification these mutants were assessed for their ability to undergo phosphorylation by 
His-Stkl. Indeed all GraR mutants could undergo phosphorylation to similar levels as 
GraR wild type. We created a triple mutant harboring mutations in all three threonine 
sites simultaneously, but following generation of this mutant it was observed that the 
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protein becomes insoluble. We were unable to purify a structurally stable triple mutant of 
GraR. Lastly we attempted to employ a number of strategies to quantify the amount of 
phosphorylation. However, it was determined that phosphorylation was below the 
detectable range of the assay employed. 
In chapter 3 we focused on translating our in vitro discovery that His-Stk 1 
phosphorylates GraR through in vivo studies. We first constructed a pMK4 plasmid that 
in S. aureus could ectopically express GraR wild type (cloned downstream of its native 
promoter). In addition, through site-directed mutagenesis we generated pMK4 variants of 
GraR that contained double mutations of the above-mentioned phosphorylation sites 
(T128A/Tl30A, T128A/T149A and T130A/T149A). We then introduced these vectors 
into S. aureus 11,.graR (graR knockout strain) and assessed complementation towards 
vancomycin resistance and cell growth. It was observed that ectopically expressed GraR 
wild type and mutant proteins could revert cell growth and vancomycin resistance back to 
wild type levels (as compared to S. aureus 6390, this is the background strain from which 
11,.graR was generated). 
Although in chapter 4 we focused on GraR, it was in an unrelated manner as 
chapters 2 and 3 and did not pertain to Stk 1. We have noticed a gap in the field where 
GraR, and thus the GraSR system, has constantly been studied from the point of 
antimicrobial peptide resistance. Our goal was to investigate whether GraR was involved 
in other pathways that may have been overlooked. We examined in vivo the S. aureus 
11,.graR strain and discovered novel phenotypes that have not been previously reported. To 
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confirm GraR involvement, we complemented the 11graR strain with a pMK4 ectopically 
expressing either a wild type or a mutant copy of GraR. The mutant copy was generated 
though site-directed mutagenesis, where the GraS-mediated phosphorylation site on 
GraR, aspartic acid residue 51, was mutated to asparagine; thus restricting the protein 
from receiving phosphory la ti on signals from GraS. 
It was observed that 11graR, under non-stressed conditions, reached stationary 
phase earlier as compared to the 6390 wild type strain. Furthermore it was observed that 
upon reaching stationary phase the 11graR strain yielded three times less cells as 
compared to the wild type. This is an indication that absence of the graR gene leads to 
abnormal cell growth. Upon complementing the ~graR strain with ectopically expressed 
GraR-WT cell growth was restored. However, when complementing with GraR-D51N 
cell growth remained abnormal. Thus ectopically expressed mutant GraR-D5 lN is not 
enough to revert the phenotype back to normal, it is also dependent on the aspartic acid 
residue at position 51. 
The highlight of this thesis was the observation that 11graR contains a 
subpopulation of cells that form dual septa. This morphological defect supports the notion 
that graR is involved in cell growth. It was also observed that 11graR became more 
sensitive towards Congo Red dye. However, through complementation we were unable to 
revert resistance back to wild type levels. It was observed that 11dltA was not sensitive 
towards Congo Red. Lastly, isolation of 11graR wall teichoic acids revealed significant 
changes in composition. Analysis of wall teichoic acid by gel electrophoresis revealed 
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that fj.graR wall teichoic acid migrated faster than wild type 6390. Nuclear magnetic 
resonance analysis, in collaboration with Dr. Hunter (The NMR Facility, York 
University) suggested that /j.graR wall teichoic acids have alterations in sugar 
modifications within their backbone. It should be noted that complementing the /j.graR 
strain with ectopically expressed GraR wild type reverted wall teichoic acid composition 
back to normal, whereas complementation with GraR-D51N could not. 
5.2 Future direction 
The observation that His-Stkl phosphorylates GraR in vitro is an interesting one. 
We have provided solid evidence that this phosphorylation event is specific, but it 
remains to be determined what the physiological role is. Future work will need to address 
if this phosphorylation event indeed occurs in vivo, which could be accomplished through 
mass spectrometry analysis of S. aureus specifically targeting the peptides containing the 
phosphorylation sites. Another strategy, if signal from S. aureus is below detectable 
range, is to express both Stkl and GraR from same plasmid (pETDuet-1) in E. coli, and 
analyze phosphorylation states. As we were unable to show decreased phosphorylation 
through in vitro kinase assays with single mutants, it would be interesting to probe 
whether His-Stkl can phosphorylate GraR double mutants that harbor two mutated sites. 
Given GraR is a transcription factor, future work should also address whether GraR 
affinity for DNA increases or decreases. However, this may be difficult until the signaling 
cascade of Stkl-GraR is characterized. 
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Our work has demonstrated that lack of graR gene leads to alterations in cell 
growth, division and wall teichoic acid maintenance. Future work should focus on the 
molecular mechanisms that govern these phenotypes. Of particular interest would be the 
examination of ~graR and why subpopulations of cells form dual septa. Understanding 
why these cells form dual septa may shed light on the unusual growth patterns of ~graR. 
It is also unclear whether alterations in wall teichoic acids play a role in cell growth and 
division. But, it is likely phosphorylation of GraR at aspartic acid 51 is important for 
proper activity and thus future studies should address DNA-binding of phosphorylated 
versus non-phosphorylated GraR. A gene that GraR may bind and regulate is tarM. 
Lastly, flgraR was observed to become more sensitive towards Congo Red but 
complementation studies were unable to revert resistance to wild type levels. Thus future 
studies should experiment with other flgraR strains and address whether Congo Red 
sensitivity is reproducible. 
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Appendix A 
LC-MS/MS of His-Stkl prepared with Scaffold 3.6.1 and analyzed by liquid 
chromatography-mass spectrometry (LC-MS/MS) at the Advanced Protein Technology 
Centre, The Hospital for Sick Children (Toronto, Canada). Figure shows protein of 
interest, separated on 12.5% SDS-PAGE, belongs to His-Stkl. 
gil359830238 (100%), 74,423.7 Da 
Serine/threonine protein kinase PrkC. regulator of stationary phase [Staphylococcus aureus subsp. aureus MOB] 
51 unique peptides, 111 unique spectra, 411 total spectra, 352/664 amino acids (53% coverage) 
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D 
MS/MS spectra of tryptic GraR peptides containing the Stkl phosphorylation sites 
Sequence coverage illustrated by the labeling of fragment ions of each peptide according 
to Roepstorff-Fohlmann-Biemann nomenclature. (A) The MS/MS spectrum of the 
peptide 146-GDDTIFLSK-154 from untreated GraR. (B) The MS/MS spectrum of the 
phosphopeptide 146-GDDtIFLSK-154 from GraR incubated with ATP in the presence of 
Stkl. (C) The MS/MS spectrum of the peptide 128-TLTWQDAVVDLSK-140 from 
untreated GraR. (D) The MS/MS spectrum of the phosphopeptide 128-
TLtWQDAVVDLSK-140 from GraR incubated with ATP in the presence of Stkl. 
(lowercase letters in description indicate the phosphoamino acids). 
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Appendix C 
Expression of GraR-triple mutant, all gels resolved by 15% SDS-PAGE 
25°C Overnight, 0.5 mM IPTG 
25°C Overnight, 0.5 mM IPTG 
Colony 1 2 3 4 5 
PSPSPS PSPS 
• Q-.. ~---~---~· 
ll'' -... .... 
S = supernatant 
P =pellet 
1-GraR WT 
2 - uninduced, 0 hr 
3 - colony 1 
4-colony 2 
5 -colony 3 
6-colony 4 
7 -colony 5 
8 - uninduced, overnight 
18°C Overnight, varying IPTG 
1 2 3 4 5 6 78 9 ;. . --- ... . ~.- ~-~-
- -·-·· ~- _ .. _ 
Ue""'"iiis~ 
...., ..... \,""' -· 
'-lll•ii~ •• 
'-----~__,,,,,,,=-=·"""""-- - • 
1- grar WT 
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2 - uninduced 0 time 
3 - 0.1 mM IPTG, total 
4 - 0.1 mM IPTG, pellet 
5 - 0.1 mM IPTG, supernatant 
6 - 0.5 mM IPTG, total 
7 - 0.5 mM IPTG, pellet 
8 - 0.5 mM IPTG, supernatant 
9 - uninduced, 18 hours 
Appendix D 
Sequencing result for pSTBlue-1 with insert P native:graR 
Colony F sequenced 
~ : m1m1: ~ _ : _ ~caaatactactagtag 
aagatgacaatactttgtttcaagaattgaaaaaagaattagaacaatgggattttaatgttgctggtattgaagatttcggcaaagta 
atggatacatttgaaagttttaatcctgaaattgttatattggatgttcaattacctaaatatgatgggttttattggtgcagaaaaatgag 
agaagtttccaacgtaccaatattatttttatcatctcgtgataatccaatggatcaagtgatgagtatggaacttggcgcagatgatt 
atatgcaaaaaccgttctataccaatgtattaattgctaaattacaagcgatttatcgtcgtgtctatgagtttacagctgaagaaaaac 
gtacattgacttggcaagatgctgtcgttgatctatcaaaagatagtatacaaaaaggtgatcagacgattttcctgtccaaaacaga 
aatgattatattagaaattcttattaccaaaaaaaatcaaatcgtttcgagagatacaattatcactgcattatgggatgatgaagcatt 
tgttagtgataatacgttaacagtaaatgtgaatcgtttacgaaaaaaattatctgaaattagtatggatagtgcaatcgaaacaaaa 
gtaggaaaaggatatatggctcatgaataagtcgactagcatcacgaattctggatccgatacgtaacgagtct 
MW is the promoter region of the graXSR operon (Pnative) 
Bm@] ( catatg) - contains A TG of GraR 
In red is the 8325 graR gene 
**Everything before and after the restriction sites flanking the promoter/gene is part of 
pSTBlue-1 
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Appendix E 
Sequencing result for pMK4 with insert P native:graR 
Colony B sequenced 
~~mi mimimi : ~al : mi : : mi : : : 
ml: : m: : :~catatgcaaatactactagtagaagatgacaatactttgtttcaagaattgaaa 
aaagaattagaacaatgggattttaatgttgctggtattgaagatttcggcaaagtaatggatacatttgaaagmtaatcctgaaatt 
gttatattggatgttcaattacctaaatatgatgggttttattggtgcagaaaaatgagagaagtttccaacgtaccaatattatttttatc 
atctcgtgataatccaatggatcaagtgatgagtatggaacttggcgcagatgattatatgcaaaaaccgttctataccaatgtatta 
attgctaaattacaagcgatttatcgtcgtgtctatgagtttacagctgaagaaaaacgtacattgacttggcaagatgctgtcgttga 
tctatcaaaagatagtatacaaaaaggtgatcagacgattttcctgtccaaaacagaaatgattatattagaaattcttattaccaaaa 
aaaatcaaatcgtttc gagagatacaattatcactgcattatgggatgatgaagcatttgttagtgataatac gttaacagtaaatgtg 
aatcgtttacgaaaaaaattatctgaaattagtatggatagtgcaatcgaaacaaaagtaggaaaaggatatatggctcatgaataa 
gtcgacctgcagccaagcttggcgtaatcatggtcatagctgtttcctgtgtgaaattgttatccgctcacaattccacacaacat 
acgagcc 
- is the promoter region of the graXSR operon (P native) 
Ndel (catatg)- contains ATG of GraR 
In red is the 8325 graR gene 
**Everything before and after the restriction sites flanking the promoter/gene is part of 
pMK4 
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Appendix F 
Raw data from vancomycin MIC experiment. The darker the box the higher the OD6oO.· 
Vancomycin µg/mL 
6390 
jj,_graR 
jj,_graR+pMK4:graR-WT 
jj,_graR+pMK4:graR-T128AIT130A 
jj,_graR+pMK4:graR-T128AIT149A 
jj,_graR+pMK4:graR-Tl 30A/Tl 49A 
jj,_graR+pMK4:graR-TRIPLE 
52 
52 
150 
4 
0.051 
0.05 
0.051 
0.05 
0.051 
0.052 
0.051 
Appendix G 
PCR confirmation that figraR strain contains the msr R gene. Size of msr R product 
expected to be 738 bp. Truncated protein primers used. Cells used directly for PCR, thus 
variation in cell number could account for band intensity. 
1 2 3 4 
~ ~r-:---.~.·· 
1 -marker 
2 - MU50 genome 
3 -6390 
4 - b.graR 
1000 
750 ..__ 4 msrR 
500 
250 ~ 
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Appendix H 
Congo Red susceptibility of MarO. MarO MIC towards Congo Red is 4µg/mL. At 10 
µg/mL of Congo Red growth is observed only at 106 cells, likely because cells are 
growing on top of each other. Experiment showcases the sensitivity of the experiment. 
~taro 
6 5 4 3 2 I 
10 10 10 10 10 10 Cells 
D o O o 4t 00 ~ 
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TSA 
10 µg/mLCRA 
50 µg/mL 
100 µg/mL 
Appendix I 
NMR 2D-HSQC of TCA-extracted WTA from 6390 and b.graR 
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Appendix J 
NMR 2D-HSQC ofTCA-extracted WTA from l!J.graR complemented with pMK4-GraR-
WTorD51N 
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